ArticlePDF Available

A four-part working bibliography of neuroethics: Part 4 - Ethical issues in clinical and social applications of neuroscience

Authors:

Abstract

Background As a discipline, neuroethics addresses a range of questions and issues generated by basic neuroscientific research (inclusive of studies of putative neurobiological processes involved in moral and ethical cognition and behavior), and its use and meanings in the clinical and social spheres. Here, we present Part 4 of a four-part bibliography of the neuroethics literature focusing on clinical and social applications of neuroscience, to include: the treatment-enhancement discourse; issues arising in neurology, psychiatry, and pain care; neuroethics education and training; neuroethics and the law; neuroethics and policy and political issues; international neuroethics; and discourses addressing "trans-" and "post-" humanity. Methods To complete a systematic survey of the literature, 19 databases and 4 individual open-access journals were employed. Searches were conducted using the indexing language of the U.S. National Library of Medicine (NLM). A Python code was used to eliminate duplications in the final bibliography. Results When taken with Parts 1-3, this bibliography aims to provide a listing of international peerreviewed papers, books, and book chapters published from 2002 through 2016. While seeking to be as comprehensive as possible, it may be that some works were inadvertently and unintentionally not included. We therefore invite commentary from the field to afford completeness and contribute to this bibliography as a participatory work-in-progress.
E D I T O R I A L Open Access
A four-part working bibliography of
neuroethics: Part 4 - Ethical issues in clinical
and social applications of neuroscience
Kira Becker
1
, John R. Shook
2
, Martina Darragh
3
and James Giordano
4*
Abstract
Background: As a discipline, neuroethics addresses a range of questions and issues generated by basic
neuroscientific research (inclusive of studies of putative neurobiological processes involved in moral and ethical
cognition and behavior), and its use and meanings in the clinical and social spheres. Here, we present Part 4 of a
four-part bibliography of the neuroethics literature focusing on clinical and social applications of neuroscience, to
include: the treatment-enhancement discourse; issues arising in neurology, psychiatry, and pain care; neuroethics
education and training; neuroethics and the law; neuroethics and policy and political issues; international
neuroethics; and discourses addressing "trans-" and "post-" humanity.
Methods: To complete a systematic survey of the literature, 19 databases and 4 individual open-access journals
were employed. Searches were conducted using the indexing language of the U.S. National Library of Medicine
(NLM). A Python code was used to eliminate duplications in the final bibliography.
Results: When taken with Parts 1-3, this bibliography aims to provide a listing of international peerreviewed papers,
books, and book chapters published from 2002 through 2016. While seeking to be as comprehensive as possible, it
may be that some works were inadvertently and unintentionally not included. We therefore invite commentary
from the field to afford completeness and contribute to this bibliography as a participatory work-in-progress.
Keywords: Neuroethics, Neuroscience, Neurology, Psychiatry, Bibliography
Introduction
In A Theory of Justice, philosopher John Rawls proposed
that the ethico-legal structure of society is based those ways
that constructs of rightness or wrongness are applied to
any situation [1]. The citations in this fourth part of a bibli-
ography of neuroethics reflect works that focus upon the
social aspects of research and clinical advances in the brain
sciences. To be sure, neuroscience is not confined to the la-
boratory, as the demand for, and concomitant concerns
about bench-to-bedsidetranslation are increasing. Ques-
tions about the use of neuroscientific approaches to define
normality; the meaning and relevance of what constitutes
(and who receives) treatment or enhancement; the ability
and validity of using neuroimaging to depict consciousness;
and the trajectory of human biology and society, each and
all arise from the interfluence of neuroscientific advance-
ment and social expectation(s) and anxieties. Addressing
these questions is, and will not be, simple or easy. As Illes
et al. have noted, “…frontier technology that is able to
touch on our personhood, especially in bioscience and in-
formation science, is shaping our future[2].
The direction of brain science can, and arguably should
be guided by neuroethics. The neuroethics literature “…
seeks to give neuroscience what bioethics and the ethical,
legal and social implication (ELSI) programs provided for
the human genome project: a platform for scientists,
lawyers, philosophers, sociologists, other scholars and the
general public to interact and discuss the future of neuro-
science[3]. In this way, the literature and this bibliog-
raphy provide a view to the discourse to date, and the
foundation upon which to build engagement at present
and in the future. To be sure, this future will ever more
involve, and affect the world stage, as brain science be-
comes an increasingly international enterprise. Viewed
* Correspondence: james.giordano@georgetown.edu
4
Neuroethics Studies Program, Pellegrino Center for Clinical Bioethics, and
Department of Neurology, Georgetown University Medical Center,
Washingotn, DC, USA
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Becker et al. Philosophy, Ethics, and Humanities in Medicine (2017) 12:1
DOI 10.1186/s13010-017-0043-y
from an international vantage point, neuroethics has the
potential to go beyond “…absolutism, cultural essential-
isms, and unrealistic ethical philosophies, [and] arrives at
a small set of principles about proper human flourishing
that are more culturally inclusive and cosmopolitan in
spiritempowerment, non-obsolescence, self-creativity,
and citizenship[4].
The inclusion of citizenshipis important, because both
professionals (in the natural, physical, life and social
sciences, medicine, and government) and various publics
“…must have the power defined by quality of know-
ledge and ease of access to help shape that future.It
is in this spirit that a consistent goal of this bibliographic
series is to invite ongoing professional and public partici-
pation in contributing to its further development, and in
so doing bolstering the informational groundwork upon
which the future of neuroscience can stand.
The following bibliographies provide neuroethics
literature on the clinical and social implications of
neurological advances from 20022016. The bibliographies
cover a range of topics, to include:
I. Health care
a) issues in/of the treatment-enhancement discourse
b) ethical issues in neurology (including neuro-
rehabilitation)
c) ethical issues in psychiatry (including gender and
LGBT issues)
d) ethical issues in anesthesiology/pain medicine
(including addiction)
II. Neuroethics education/training
III. Neuroethics and law
IV. Neuroethics and policy and politics
V. International neuroethics
VI.Trans/posthuman issues
Methods for systematically searching relevant litera-
ture devoted to neuroethics are identical to those
utilized in the first 3 parts of this bibliography [57].
The United States National Library of Medicines
(NLM) indexing languageMeSH (Medical Subject
Headings)was used to generate the basic search strat-
egy for each topic. MeSH contains ethics-related terms
developed for BIOETHICSLINE, a specialty database
devoted to bioethical issues produced for NLM by the
Kennedy Institute of Ethics from 19752000.
Citations were retrieved from the following databases:
1) U.S. National Library of Medicines PubMed and
NLM Catalog
2) Academic Search Premier
3) Proquest Research Library
4) JSTOR
5) WorldCat
6) Philosophers Index
7) Embase
8) BELIT
9) Web of Knowledge/Web of Science
10) Digital Public Library of America
11) Directory of Open Access Journals
12) Hathi Trust Digital Library
13)Internet Archive
14) Globethics.net
15) Neuroethics-Wikiography
These listings of citations are participatory bibliog-
raphiesin that readers are encouraged to submit
additional cites via the Commentssection of this
document or by contacting the bibliographic manager
at bioethics@georgetown.edu.
Health Care
Issues in/of the treatment-enhancement discourse
Articles:
Alberini CM, Chen DY: Memory enhancement: con-
solidation, reconsolidation and insulin-like growth
factor 2. Trends Neurosci 2012, 35(5):274-283. doi:
10.1016/j.tins.2011.12.007.
Asscher EC, Schermer M: Wish-fulfilling medicine
in practice: the opinions and arguments of lay
people. J Med Ethics 2014, 40(12):837-841. doi:10.1136/
medethics-2013-101480.
Attiah MA, Farah MJ: Minds, motherboards, and
money: futurism and realism in the neuroethics of
BCI technologies.Front Syst Neurosci 2014, 8:86.
doi:10.3389/fnsys.2014.00086.
Bamford R: Unrequited: neurochemical enhancement
of love.Camb Q Healthc Ethics 2015, 24(3):355-360.
doi:10.1017/S0963180114000668.
Benanti P: Neuroenhancement in young people: cul-
tural need or medical technology? AJOB Neurosci
2010, 1(1):27-29. doi:10.1080/21507740903523210.
Beyer C, Staunton C, Moodley K: The implications of
methylphenidate use by healthy medical students
and doctors in South Africa. BMC Med Ethics 2014,
15:20. doi:10.1186/1472-6939-15-20.
Boldt J: [Doping, enhancement, betterment: tasks
of tomorrows medicine?]. Dtsch Med Wochenschr
2010, 135(37):1823-1826. doi:10.1055/s-0030-1263324.
Bolt LL: True to oneself? broad and narrow ideas on
authenticity in the enhancement debate.Theor Med
Bioeth 2007, 28(4):285-300. doi:10.1007/s11017-007-9039-8.
Bostrom N, Sandberg A: Cognitive enhancement:
methods, ethics, regulatory challenges.Sci Eng Ethics
2009, 15(3):311-341. doi:10.1007/s11948-009-9142-5.
Brewer CD, DeGrote H: Regulating methylphenidate:
enhancing cognition and social inequality.Am J Bioeth
2013, 13(7):47-49. doi:10.1080/15265161.2013.794886.
Becker et al. Philosophy, Ethics, and Humanities in Medicine (2017) 12:1 Page 2 of 32
Brühl AB, Sahakian BJ: Drugs, games, and devices
for enhancing cognition: implications for work and
society. Ann N Y Acad Sci 2016, 1369(1):195-217.
doi:10.1111/nyas.13040.
Bruhn C: [Neuroenhancement: doping for the
brain]. Dtsch Med Wochenschr 2009, 134(40): 35.
doi:10.1055/s-0028-1124088.
Busardò FP et al.: From clinical application to
cognitive enhancement: the example of methyl-
phenidate. Curr Neuropharmacol 2016, 14(1):17-27.
doi: 10.2174/1570159X13666150407225902.
Cabrera L, Weckert J: Human enhancement and
communication: on meaning and shared understand-
ing. Sci Eng Ethics 2013, 19(3):1039-1056. doi:10.1007/
s11948-012-9395-2.
Cabrera LY, Elger BS: Memory interventions in the
criminal justice system: some practical ethical consid-
erations. J Bioeth Inq 2016, 13(1):95-103. doi:10.1007/
s11673-015-9680-2.
Cabrera LY, Reiner PB: Understanding public (mis)-
understanding of tDCS for enhancement. Front Integr
Neurosci 2015, 9:30. doi:10.3389/fnint.2015.00030.
Caplan AL: Important treatment, wrong diagnosis:
enhancement is not to blame for the abuse of auton-
omy.Cerebrum 2004, 6(4):25-26.
Caplan AL, McHugh PR: Shall we enhance? a debate.
Cerebrum 2004, 6(4):13-29.
Clausen J: Conceptual and ethical issues with brain-
hardware interfaces. Curr Opin Psychiatry 2011,
24(6):495-501. doi:10.1097/YCO.0b013e32834bb8ca.
Cooze J, Gillam L: Democratizing psychotropic
neuroenhancement.AJOB Neurosci 2010, 1(1):19-20.
doi:10.1080/21507740903504491.
Danaher J: An evaluative conservative case for bio-
medical enhancement.J Med Ethics 2016, 42(9):611-618.
doi:10.1136/medethics-2015-103307.
de Jongh R, Bolt I, Schermer M, Olivier B: Botox for
the brain: enhancement of cognition, mood and pro-
social behavior and blunting of unwanted memories.
Neurosci Biobehav Rev 2008, 32(4):760-776. doi:10.1016/
j.neubiorev.2007.12.001.
Dietz P, Soyka M, Franke AG: Pharmacological
neuroenhancement in the field of economics-poll
results from an online survey. Front Psychol 2016,
7:520. doi:10.3389/fpsyg.2016.00520.
DubljevićV: Prohibition or coffee shops: regulation of
amphetamine and methylphenidate for enhancement
usebyhealthyadults.Am J Bioeth 2013, 13(7):23-33.
doi:10.1080/15265161.2013.794875.
DubljevićV: Response to open peer commentaries
on "prohibition or coffee shops: regulation of am-
phetamine and methylphenidate for enhancement
use by healthy adults". Am J Bioeth 2014, 14(1):W1-
W8. doi:10.1080/15265161.2014.862417.
Earp BD, Sandberg A, Kahane G, Savulescu J:
When is diminishment a form of enhancement?
Rethinking the enhancement debate in biomedical
ethics.Front Syst Neurosci 2014, 8:12. doi:10.3389/
fnsys.2014.00012.
Eberl JT: A Thomistic appraisal of human enhance-
ment technologies. Theor Med Bioeth 2014, 35(4):289-
310. doi:10.1007/s11017-014-9300-x.
Eßmann B: Human enhancement: revisiting the ethical
framework.Med Health Care Philos 2011, 14(4):425-427.
doi:10.1007/s11019-011-9350-z.
Erler A: Does memory modification threaten our au-
thenticity? Neuroethics 2011, 4(3): 235-249. doi:10.1007/
s12152-010-9090-4.
Faber NS, Savulescu J, Douglas T: Why is cognitive en-
hancement deemed unacceptable? the role of fairness,
deservingness, and hollow achievements.Front Psychol
2016, 7:232. doi: 10.3389/fpsyg.2016.00232.
Farah MJ, Smith ME, Ilieva I, Hamilton RH: Cognitive
enhancement.Wiley Interdiscip Rev Cogn Sci 2014,
5(1):95-103. doi:10.1002/wcs.1250.
Farah MJ et al.: Neurocognitive enhancement: what
can we do and what should we do? Nat Rev Neurosci
2004, 5(5):421-425. doi:10.1038/nrn1390.
Farah MJ: The unknowns of cognitive enhance-
ment.Science 2015, 350(6259):379-380. doi:10.1126/
science.aad5893.
Faulmüller N, Maslen H, de Sio FS: The indirect psy-
chological costs of cognitive enhancement.Am J Bioeth
2013, 13(7):45-47. doi:10.1080/15265161.2013.794880.
Fenton A: Buddhism and neuroethics: the ethics of
pharmaceutical cognitive enhancement.Dev World Bioeth
2009, 9(2):47-56. doi:10.1111/j.1471-8847.2007.00226.x.
Fleischman A et al.: Dealing with the long-term
social implications of research. Am J Bioeth 2011,
11(5):5-9. doi:10.1080/15265161.2011.568576.
Flower K et al.: Efficacy, safety, and ethics of cos-
metic neurology far from settled. Clin Pharmacol Ther
2010, 88(4):461-463. doi:10.1038/clpt.2010.194.
Fond G et al.: Innovative mechanisms of action for
pharmaceutical cognitive enhancement: a systematic
review. Psychiatry Res 2015, 229(1-2):12-20. doi:10.1016/
j.psychres.2015.07.006.
Fond G et al.: (Mis)use of prescribed stimulants in
the medical student community: motives and behav-
iors: a population-based cross-sectional study.
Medicine (Baltimore) 2016, 95 (16):e3366. doi:10.1097/
MD.0000000000003366.
Forlini C, Racine E: Considering the causes and im-
plications of ambivalence in using medicine for en-
hancement. Am J Bioeth 2011, 11(1):15-17. doi:
10.1080/15265161.2011.534952.
Forlini C, Racine E, Vollmann J, Schildmann J: How
research on stakeholder perspectives can inform
Becker et al. Philosophy, Ethics, and Humanities in Medicine (2017) 12:1 Page 3 of 32
policy on cognitive enhancement. Am J Bioeth 2013,
13(7):41-43. doi:10.1080/15265161.2013.794882.
Forlini C et al.: Navigating the enhancement land-
scape: ethical issues in research on cognitive enhancers
for healthy individuals. EMBO Rep 2013, 14(2):123-128.
doi:10.1038/embor.2012.225.
Forlini C, Racine E: Stakeholder perspectives and
reactions to academiccognitive enhancement:
unsuspected meaning of ambivalence and analogies.
Public Underst Sci 2012, 21(5):606-625. doi:10.1177/
0963662510385062.
Franke AG, Northoff R, Hildt E: The case of pharma-
cological neuroenhancement: medical, judicial and
ethical aspects from a German perspective. Pharma-
copsychiarty 2015, 48(7): 256-264. doi:10.1055/s-0035-
1559640.
Franke AG et al.: [Characteristics of university
students using stimulants for cognitive enhance-
ment: a pilot study]. Psychiatr Prax 2012, 39(4):174-
180. doi: 10.1055/s-0031-1298900.
Franke AG, Soyka M: [Pharmacological cognitive en-
hancement from a perspective of misuse and
addiction]. Fortschr Neurol Psychiatr 2015, 83(2):83-90.
doi: 10.1055/s-0034-1398935.
Franke AG, Lieb K: [Pharmacological neuroenhance-
ment and brain doping: chances and risks]. Bundesge-
sundheitsblatt Gesundheitsforschung Gesundheitsschutz
2010, 53(8):853-859. doi:10.1007/s00103-010-1105-0.
Frati P et al.: Smart drugs and synthetic androgens for
cognitive and physical enhancement: revolving doors of
cosmetic neurology. Curr Neuropharmacol 2015, 13(1):5-
11. doi:10.2174/1570159X13666141210221750.
Garasic MD, Lavazza A: Moral and social reasons to
acknowledge the use of cognitive enhancers in
competitive-selective contexts. BMC Med Ethics 2016,
17:18. doi:10.1186/s12910-016-0102-8.
Gini A, Rossi J, Giordano J: Considering enhancement
(and/or treatment): on the need to regard contingency
and develop dialectic evaluation.AJOB Neurosci
2010,1(1):25-27. doi:10.1080/21507740903504392.
Glannon W: Altering the brain and mind.Hastings
Cent Rep 2008, 38(4):46-47. doi:10.1353/hcr.0.0039.
Glannon W: Psychopharmacological enhancement.
Neuroethics 2008, 1(1):45-54. doi: 10.1007/s12152-008-
9005-9.
Gleaves J: A new conceptual gloss that still lacks luster:
critiquing Morgan's treatment-enhancement distinc-
tion.JPhilosSport2011, 38(1):103-112. doi:10.1080/
00948705.2011.9714552.
Greely HT: Knowing sin: making sure good science
doesntgobad.Cerebrum 2006, 1-8.
Greely HT: Some first steps toward responsible use of
cognitive-enhancing drugs by the healthy.Am J Bioeth
2013, 13(7):39-41. doi:10.1080/15265161.2013.795823.
Hall W, Partridge B, Lucke J: Constraints on regu-
latory options for putatively cognitive enhancing
drugs.Am J Bioeth 2013, 13(7):35-37. doi:10.1080/
15265161.2013.795825.
Hall WD, Lucke JC: The enhancement use of neuro-
pharmaceuticals: more scepticism and caution needed.
Addiction 2010, 105(12):2041-2043. doi:10.1111/j.1360-
0443.2010.03211.x.
Holtug N: Equality and the treatment-enhancement
distinction.Bioethics 2011, 25(3):137-144. doi:10.1111/
j.1467-8519.2009.01750.x.
Huggins J, Simmerling M: Normal functioning and
the treatment/enhancement distinction: an oppor-
tunity based assessment.J Relig Health 2014,
53(4):1214-1222. doi:10.1007/s10943-014-9882-7.
Hyman SE: Cognitive enhancement: promises
and perils.Neuron 2011, 69(4):595-598. doi:10.1016/
j.neuron.2011.02.012.
Jain KK: Future of nanomedicine: impact on health-
care & society. Nanomedicine (Lond) 2015, 10(21):3199-
3202. doi:10.2217/nnm.15.153.
Jensen C, Forlini C, Partridge B, Hall W: Australian
university studentscoping strategies and use of
pharmaceutical stimulants as cognitive enhancers.
Front Psychol 2016, 7:277. doi:10.3389/fpsyg.2016.00277.
Jones DG: Enhancement: are ethicists excessively in-
fluenced by baseless speculations? Med Humanit
2006, 32(2):77-81. doi:10.1136/jmh.2005.000234.
Kamm FM: Is there a problem with enhancement? Am
J Bioeth 2005, 5(3):5-14. doi:10.1080/15265160590945101.
Kraemer F: Me, myself and my brain implant: deep
brain stimulation raises questions of personal au-
thenticity and alienation. Neuroethics 2013, 6:483-497.
doi:10.1007/s12152-011-9115-7
KrstićP: The better human, the better than human:
limits of enhancement.Filozofija i Društvo 2012,
23(2):124-144. doi:10.2298/FID1202124K.
Kuiken T: Nanomedicine and ethics: is there anything
new or unique? Wiley Interdiscip Rev Nanomed Nanobio-
technol 2011, 3(2):111-118. doi:10.1002/wnan.90.
Lamkin M: Regulating identity: medical regulation
as social control.BYU L Rev 2016, 2016(2):503-574.
Lane MA, Ingram DK, Roth GS: The serious search
for an anti-aging pill.Sci Am 2002, 287 (2):36-41.
doi:10.1038/scientificamerican0802-36.
Larrieu P: Les enjeux éthiques de la neuroamélioration
[ethical issues of the neuroimprovement].Médecine &
Droit 2014, 126:61-65. doi:10.1016/j.meddro.2014.03.003.
Larriviere D, Williams MA: Neuroenhancement: wis-
dom of the masses or false phronesis?Clin Pharma-
col Ther 2010, 88(4):459-461. doi:10.1038/clpt.2010.140.
Levy N: There may be costs to failing to enhance, as
well as to enhancing.Am J Bioeth 2013, 13(7):38-39.
doi:10.1080/15265161.2013.796222.
Becker et al. Philosophy, Ethics, and Humanities in Medicine (2017) 12:1 Page 4 of 32
Liakoni E et al.: The use of prescription drugs, rec-
reational drugs, and "soft enhancers" for cognitive
enhancement among Swiss secondary school stu-
dents. PLoS One 2015, 10(10):e0141289. doi:10.1371/
journal.pone.0141289.
Lucas MS: Baby steps to superintelligence: neuro-
prosthetics and children. J Evol Technol 2012,
22(1):132-145.
Lucke J. & Patridge B: Towards a smart population:
a public health framework for cognitive enhance-
ment. Neuroethics 2013, 6: 419. doi:10.1007/s12152-012-
9167-3.
MacDonald C, Poirier N: Pediatric neuroenhance-
ment: full steam ahead, in a leaky boat? AJOB Neu-
rosci 2010, 1(1):33-35. doi:10.1080/21507740903504517.
Maier LJ, Haug S, Schaub MP: Author's response on
Arria (2016): intention matters-using the terminology
'pharmacological neuroenhancement' as a behav-
ioural definition based on the assumed functionality.
Addiction 2016, 111(5):938-939. doi:10.1111/add.13331.
Maier LJ et al.: Pharmacological cognitive enhance-
ment in healthy individuals: a compensation for cogni-
tive deficits or a question of personality? PLoS One
2015, 10 (6):e0129805. doi:10.1371/journal.pone.0129805.
Maier LJ, Haug S, Schaub MP: Prevalence of and mo-
tives for pharmacological neuroenhancement in
Switzerlandresults from a national Internet panel.
Addiction 2016, 111(2):280-295. doi:10.1111/add.13059.
Maier LJ et al.: Swiss university studentsatti-
tudes toward pharmacological cognitive enhance-
ment. PLoS One 2015, 10(12):e0144402. doi:10.1371/
journal.pone.0144402.
Maier LJ, Liechti ME, Herzig F, Schaub MP: To dope
or not to dope: neuroenhancement with prescription
drugs and drugs of abuse among Swiss university stu-
dents. PLoS One 2013, 8(11):e77967. doi:10.1371/
journal.pone.0077967.
Maslen H, Earp BD, Kadosh RC, Savulescu J: Brain
stimulation for treatment and enhancement in chil-
dren: an ethical analysis.Front Hum Neurosci 2014,
8:1-5. doi:10.3389/fnhum.2014.00953.
Maslen H et al.: The regulation of cognitive en-
hancement devices: refining Maslen et al.s model.J
Law Biosci 2015, 2(3):754-767. doi:10.1093/jlb/lsv029.
Mauron A, Hurst S: From Ritalin to malignant
teaching the fuzzy borders of neuroenhance-
ment.AJOB Neurosci 2010, 1(1):31-33. doi:10.1080/
21507740903504384.
McCrickerd J: Sudden discontinuation and the sub-
jective character of experience: a reason to resist psy-
chotropic neuroenhancements.AJOB Neurosci 2010,
1(1):23-25. doi:10.1080/21507740903504459.
Mendelsohn D, Lipsman N, Bernstein M: Neurosurgeons
perspectives on psychosurgery and neuroenhancement: a
qualitative study at one center. J Neurosurg 2010, 113(6):
1212-1218. doi:10.3171/2010.5.JNS091896.
Mohamed AD, Sahakian BJ: The ethics of elective
psychopharmacology.Int J Neuropsychopharmacol
2012, 15(4):559-571. doi:10.1017/S146114571100037X.
Mohamed AD: Neuroethical issues in pharmaco-
logical cognitive enhancement. Wiley Interdiscip Rev
Cogn Sci 2014, 5(5):533-549. doi:10.1002/wcs.1306.
Moutaud B: Neuromodulation technologies and the
regulation of forms of life: exploring, treating, enhan-
cing.Med Anthropol 2016, 35(1):90-103. doi:10.1080/
01459740.2015.1055355.
Normann C, Boldt J, Maio G, Berger M: [Options, limits
and ethics of pharmacological neuroenhancement]. Ner-
venarzt 2010, 81(1):66-74. doi:10.1007/s00115-009-2858-2.
Ori L: Should children have equal access to
neuroenhancements? AJOB Neurosci 2010, 1(1):21-23.
doi:10.1080/21507740903504442.
Ott R: Neuroenhancement - perspectives of Swiss
psychiatrists and general practitioners. Swiss Med
Wkly 2012, 142:w13707. doi:10.4414/smw.2012.13707.
Outram SM, Racine E: Examining reports and policies
on cognitive enhancement: approaches, rationale, and
recommendations. Account Res 2011, 18(5):323-341.
doi:10.1080/08989621.2011.606734.
Outram SM: Negotiating an inevitable future? AJOB
Neurosci 2010, 1(1):29-31. doi:10.1080/21507740903504426.
Outram SM: The use of methylphenidate among
students: the future of enhancement? J Med Ethics
2010, 36(4):198-202. doi:10.1136/jme.2009.034421.
Parens E: Authenticity and ambivalence: toward un-
derstanding the enhancement debate.Hastings Cent
Rep 2005, 35(3):34-41. doi:10.1353/hcr.2005.0067.
Parens E: On good and bad forms of medicalization.Bio-
ethics 2013, 27(1):28-35. doi:10.1111/j.1467-8519.2011.01885.x.
Partridge BJ et al.: Smart drugs as common as cof-
fee: media hype about neuroenhancement. PLoS One
2011, 6(11):e28416. doi:10.1371/journal.pone.0028416.
Persson I, Savulescu J: The perils of cognitive en-
hancement and the urgent imperative to enhance the
moral character of humanity. J Appl Philos 2008,
25(3):162-177. doi:10.1111/j.1468-5930.2008.00410.x.
Penrose B: Sandel on enhancement : a response to
Van Niekerk.
S Afr J Philos 2016, 35(2):145-163. doi:10.1080/
02580136.2016.1162038.
Pickersgill M, Hogle L: Enhancement, ethics and so-
ciety: towards an empirical research agenda for the
medical humanities and social sciences. Med Humanit
2015, 41(2):136-142. doi:10.1136/medhum-2015-010718.
Ponnet K et al.: Determinants of physicianspre-
scribing behaviour of methylphenidate for cognitive
enhancement. Psychol Health Med 2014, 19(3):286-295.
doi:10.1080/13548506.2013.802361.
Becker et al. Philosophy, Ethics, and Humanities in Medicine (2017) 12:1 Page 5 of 32
Racine E, Forlini C: Responding to requests from adult
patients for neuroenhancements: guidance of the Eth-
ics, Law and Humanities Committee.Neurology 2010,
74(19):1555-1556. doi:10.1212/WNL.0b013e3181d8a54a.
Racine E et al.: The value and pitfalls of specula-
tion about science and technology in bioethics: the
case of cognitive enhancement. Med Health Care
Philos 2014, 17(3):325-337. doi:10.1007/s11019-013-
9539-4.
Ragan CI, Bard I, Singh I, Independent Scientific
Committee on Drugs: What should we do about student
use of cognitive enhancers? an analysis of current evi-
dence. Neuropharmacology 2013, 64:588-595. doi:10.1016/
j.neuropharm.2012.06.016.
Ray KS: Not just "study drugs" for the rich: stimu-
lants as moral tools for creating opportunities for
socially disadvantaged students.Am J Bioeth 2016,
16(6):29-38. doi:10.1080/15265161.2016.1170231.
Rodríguez B: Sobre la relevancia moral de la distin-
ción mejora-tratamiento [on the moral relevance of
the enhancement treatment distinction].Dilemata
2012, 10:307-328.
Roduit JA, Baumann H, Heilinger JC: Human enhance-
ment and perfection. J Med Ethics 2013, 39(10):647-650.
doi:10.1136/medethics-2012-100920.
Roduit JA, Heilinger JC, Baumann H: Ideas of perfec-
tion and the ethics of human enhancement. Bioethics
2015, 29(9):622-630. doi:10.1111/bioe.12192.
Sahakian BJ, Morein-Zamir S: Neuroethical issues in
cognitive enhancement.J Psychopharmacol 2011,
25(2):197-204. doi:10.1177/0269881109106926.
Sandberg A, Bostrom N: Converging cognitive en-
hancements.Ann N Y Acad Sci 2006, 1093:201-227.
doi:10.1196/annals.1382.015.
Sandberg A: Enhancement policy and the value of in-
formation.Am J Bioeth 2013, 13(7):34-35. doi:10.1080/
15265161.2013.795826.
Sattler S, Schunck R: Associations between the big
five personality traits and the non-medical use of
prescription drugs for cognitive enhancement. Front
Psychol 2016, 6: 1971. doi:10.3389/fpsyg.2015.01971.
Sattler S, Mehlkop G, Graeff P, Sauer C: Evaluating
the drivers of and obstacles to the willingness to use
cognitive enhancement drugs: the influence of drug
characteristics, social environment, and personal
characteristics. Subst Abuse Treat Prev Policy 2014, 9:8.
doi: 10.1186/1747-597X-9-8.
Sattler S, Forlini C, Racine E, Sauer C: Impact of
contextual factors and substance characteristics on
perspectives toward cognitive enhancement. PLoS One
2013, 8(8):e71452. doi:10.1371/journal.pone.0071452.
Savulescu J: A liberal consequentialist approach to
regulation of cognitive enhancers.Am J Bioeth 2013,
13(7):53-55. doi:10.1080/15265161.2013.796220.
Schelle KJ, Faulmüller N, Caviola L, Hewstone M: Atti-
tudes toward pharmacological cognitive enhancement-
a review. Front Syst Neurosci 2014, 8:53. doi:10.3389/
fnsys.2014.00053.
Schwartz PH: Defending the distinction between
treatment and enhancement.Am J Bioeth 2005,
5(3):17-19. doi:10.1080/15265160591002755.
Selgelid MJ: An argument against arguments for en-
hancement.Stud Ethics Law Technol 2008, 1(1):12.
doi:10.2202/1941-6008.1008.
Singh I, Kelleher KJ: Neuroenhancement in young
people: proposal for research, policy, and clinical man-
agement.AJOB Neurosci 2010, 1(1):3-16. doi:10.1080/
2150774090350859.
Synofzik M: Kognition à la carte? - der wunsch nach
kognitionsverbessernden psychopharmaka in der
medizin [cognition on demand? - the wish for
cognition-enhancing drugs in medicine].Ethik Med
2006, 18(1):37-50. doi:10.1007/s00481-006-0412-3.
Synofzik M, Schlaepfer TE: Stimulating personality:
ethical criteria for deep brain stimulation in psychi-
atric patients and for enhancement purposes.Biotech-
nol J 2008, 3(12):1511-1520. doi:10.1002/biot.200800187.
Sparrow R: Enhancement and obsolescence: avoid-
ing an enhanced rat race.Kennedy Inst Ethics J 2015,
25(3):231-260. doi:10.1353/ken.2015.0015.
Trancik EK: Enhancement versus therapy in Cath-
olic neuroethics.Natl Cathol Bioeth Q 2015, 15(1):63-
72. doi:10.5840/ncbq20151517.
Vargo EJ, Petróczi A: It was me on a good day: ex-
ploring the smart drug use phenomenon in England.
Front Psychol 2016, 7:779. doi:10.3389/fpsyg.2016.00779.
Wade L, Forlini C, Racine, E: Generating genius: how
an Alzheimer's drug became considered a 'cognitive
enhancer' for healthy individuals. BMC Med Ethics
2014, 15:37. doi:10.1186/1472-6939-15-37.
Walcher-Andris E: Ethische aspekte des pharmako-
logischen cognition enhancementam beispiel des
gebrauchs von psychostimulanzien durch kinder und
jugendliche [ethical aspects of pharmacological
"cognition enhancement" using the example of the
use of psychostimulants by children and adoles-
cents].Ethik Med 2006, 18(1):27-36. doi:10.1007/
s00481-006-0411-4.
Wolff W, Baumgarten F, Brand R: Reduced self-
control leads to disregard of an unfamiliar behavioral
option: an experimental approach to the study of
neuroenhancement. Subst Abuse Treat Prev Policy
2013, 8:41. doi:10.1186/1747-597X-8-41.
Wolff W, Sandouqa Y, Brand R: Using the simple
sample count to estimate the frequency of pre-
scription drug neuroenhancement in a sample of
Jordan employees. Int J Drug Policy 2016, 31:51-55.
doi:10.1016/j.drugpo.2015.12.014.
Becker et al. Philosophy, Ethics, and Humanities in Medicine (2017) 12:1 Page 6 of 32
Wolpe PR: Treatment, enhancement, and the ethics
of neurotherapeutics.Brain Cogn 2002, 50(3):387-395.
doi:10.1016/S0278-2626(02)00534-1.
Zelli A, Lucidi F, Mallia L: The complexity of neu-
roenhancement and the adoption of a social cognitive
perspective. Front Psychol 2015, 6:1880. doi:10.3389/
fpsyg.2015.01880.
Zwart H: Limitless as a neuro-pharmaceutical experi-
ment and as a Daseinsanalyse: on the use of fiction in
preparatory debates on cognitive enhancement. Med
Health Care Philos 2014, 17(1):29-38. doi:10.1007/s11019-
013-9481-5.
Books:
Agar N: Humanitys End: Why We Should Reject Rad-
ical Enhancement. Cambridge, Mass: MIT Press; 2010.
Agar N: Liberal Eugenics: In Defence of Human En-
hancement. Malden, MA: Blackwell Publishing; 2005.
Agar N: Truly Human Enhancement: A Philosophical
Defense of Limits. Cambridge, Mass: MIT Press; 2014.
Baron J: Against Bioethics. Cambridge, MA: MIT
Press; 2006.
Blank RH: Cognitive Enhancement: Social and Public
Policy Issues. New York: Palgrave Pivot; 2015.
Basl J, Sandler RL, eds.: Designer Biology: The Ethics of
Intensively Engineering Biological and Ecological Systems.
Lanham: Lexington Books; 2013.
Bateman S et al. eds.: Inquiring Into Human Enhance-
ment: Interdisciplinary and International Perspectives.
New York: Palgrave Macmillan; 2015.
Buchanan AE: Beyond Humanity? The Ethics of Biomed-
ical Enhancement. Oxford: Oxford University Press; 2011.
Cabrera LY: Rethinking Human Enhancement: Social
Enhancement and Emergent Technologies. New York:
Palgrave Macmillan; 2015.
Cassell E: The Nature of Suffering and the Goals of
Medicine. Oxford: Oxford University Press; 2004.
Coeckelbergh M: Human Being @ Risk: Enhancement,
Technology, and the Evaluation of Vulnerability Trans-
formations. Dordrecht: Springer; 2013.
Dickenson D: Me Medicine vs. We Medicine: Reclaim-
ing Biotechnology for the Common Good. New York:
Columbia University Press; 2013.
Eilers M, Gruber K, Rehmann-Sutter C, eds: The
Human Enhancement Debate and Disability: New
Bodies for a Better Life. New York: Palgrave Macmil-
lan; 2014.
Engel AK, Friston KJ, Kragic D: The Pragmatic Turn:
Toward Action-Oriented Views in Cognitive Science.
Cambridge, Mass.: MIT Press; 2015.
Flanagan O: The Problem of the Soul: Two Visions of
Mind and How to Reconcile Them. New York, NY: Basic
Books; 2002.
Fröding B, Osika W: Neuroenhancement: How Mental
Training and Meditation Can Promote Epistemic
Virtue. Cham, Switzerland: Springer International
Publishing; 2015.
Glannon W: Bioethics and the Brain. Oxford: Oxford
University Press; 2006.
Gordijn B, Chadwick R, eds.: Medical Enhancement
and Posthumanity. Dordrecht: Springer; 2008.
Hauskeller M: Better Humans? Understanding the En-
hancement Project. Durham, UK: Acumen; 2013.
Hildt E, Franke AG: Cognitive Enhancement: An Inter-
disciplinary Perspective. Dordrecht: Springer; 2013.
Jotterand F, DubljevićV, eds.: Cognitive Enhancement:
Ethical and Policy Implications in International Perspec-
tives. New York: Oxford University Press; 2016.
Kass L: Beyond Therapy: Biotechnology and the Pursuit
of Happiness. Washington, D.C.: President's Council on
Bioethics; 2003.
Mehlman MJ: The Price of Perfection: Individualism
and Society in the Era of Biomedical Enhancement.
Baltimore: Johns Hopkins University Press; 2009.
Naam R: More Than Human: Embracing the Prom-
ise of Biological Enhancement. New York: Broadway
Books; 2005.
Parens E: Shaping Our Selves: On Technology, Flourish-
ing, and a Habit of Thinking. Oxford: Oxford University
Press; 2015.
Roduit JAR: The Case for Perfection: Ethics in the Age
of Human Enhancement. New York: Peter Lang; 2016.
Rothman SM: The Pursuit of Perfection: The Promise
and Perils of Medical Enhancement. New York: Vintage
Books; 2004.
Sadler J: Values and Psychiatric Diagnosis. Oxford:
Oxford University Press; 2005.
Savulescu J, Bostrom N, eds.: Human Enhancement.
Oxford: Oxford University Press; 2009.
Schöne-Seifert B et al.: Neuro-Enhancement : Ethik vor
neuen Herausforderungen. Paderborn: Mentis; 2009.
Schütz R, Hildt E, Hampel J: Neuroenhancement Interdis-
ziplinäre Perspektiven auf eine Kontroverse [Neuroenhance-
ment: Interdisciplinary Perspectives on a Controversy].
Bielefeld: transcript Verlag; 2016.
Sisti D, Caplan A, McCartney J: Health, Disease, and
Illness: Concepts in Medicine. Washington, D.C.:
Georgetown University Press; 2004.
Vincent JD: The Custom-Made Brain: Cerebral Plasti-
city, Regeneration, and Enhancement. New York:
Columbia University Press; 2014.
Wiseman H: The Myth of the Moral Brain: The Limits of
Moral Enhancement. Cambridge, Mass: MIT Press; 2016.
Wolpe P: Introductory Remarks to the Panel. First Meet-
ing of Neuroethics Society. Washington, D.C.; 2008.
Book Chapters:
Abney K, Lin P, Mehlman M: Military neuroenhance-
ment and risk assessment.InNeurotechnology in Na-
tional Security and Defense: Practical Considerations,
Becker et al. Philosophy, Ethics, and Humanities in Medicine (2017) 12:1 Page 7 of 32
Neuroethical Concerns. Edited by James Giordano. Boca
Raton: CRC Press; 2015:239-248.
Blank RH: Ethical and social context of cognitive
enhancement.InhisCognitive Enhancement: Social and
Public Policy Issues. New York: Palgrave Pivot; 2015:42-70.
Cabrera LY: How does enhancing cognition affect
human values? how does this translate into social
responsibility? In Ethical Issues in Behavioral Neurosci-
ence. Edited by Grace Lee, Judith Illes, Frauke Ohl.
Heidelberg: Springer; 2015:223-241.
Caplan AL: An unnatural process : why is it not in-
herently wrong to seek a cure for aging? In Fountain
of Youth: Cultural, Scientific, and Ethical Perspectives
on a Biomedical Goal. Edited by Stephen G. Post,
Robert H. Binstock. Oxford: Oxford University Press;
2004:271-285.
Caplan AL, McHugh PR: Shall we enhance? a debate.
In Defining Right and Wrong in Brain Science.Editedby
Walter Glannon. New York: Dana Press; 2007:271-288.
Chancellor B, Chatterjee A: Brain training. In
Neuroethics in Practice. Edited by Anjan Chatterjee,
Martha J. Farah. New York, NY: Oxford University Press;
2013:57-68.
Chatterjee A: Brain enhancement in healthy adults.
In Neuroethics in Practice. Edited by Anjan Chatterjee,
Martha J. Farah. New York, NY: Oxford University Press;
2013:3-15.
Conrad P, Horwitz A: Marketing of neuropsychiatric
illness and enhancement. In Neuroethics in Practice.
Edited by Anjan Chatterjee, Martha J. Farah. New York,
NY: Oxford University Press; 2013:46-56.
Dominey PF, Prescott TJ, Bohg J, Schwartz A: Implica-
tions of action-oriented paradigm shifts in cognitive
science.InThe Pragmatic Turn: Toward Action-
Oriented Views in Cognitive Science. Edited by Andreas
K. Engel, Karl Friston, Danica Kragic. Cambridge, Mass.:
MIT Press; 2015:333-356.
Farah MJ et al.: Neurocognitive enhancement: what
can we do and what should we do? In Defining Right
and Wrong in Brain Science. Edited by Walter Glannon.
New York: Dana Press; 2007:289-301.
Gini A, Giordano J: The human condition and strivings
to flourish.InScientific and Philosophical Perspectives in
Neuroethics. Edited by James J. Giordano, Bert Gordijn.
Cambridge: Cambridge University Press; 2010:343-354.
Glannon W: Cognitive enhancement. In his Brain,
Body, and Mind. New York, NY: Oxford University
Press, Inc.; 2011:115-145.
Klitzman R: Clinicians, patients, and the brain.In
Neuroethics: Defining the Issues in Theory, Practice, and
Policy. Edited by Judith Illes. Oxford: Oxford University
Press; 2006:229-244.
Parens E: How far will the treatment/enhancement
distinction get us as we grapple with new ways to
shape ourselves? In Neuroethics: Mapping the Field.
Edited by Steven J. Marcus. New York: Dana Press;
2002:152-158.
Presidential Commission for the Study of Bioethical Is-
sues. Cognitive enhancement and beyond. In their
Gray Matters: Topics at the Intersection of Neuroscience,
Ethics, and Society (Vol. 2). Washington, DC: Presiden-
tial Commission for the Study of Bioethical Issues;
2015:27-52.
Racine E: Enhancement of performance with neuro-
pharmaceuticals: pragmatism and the culture wars.
In his Pragmatic Neuroethics: Improving Treatment and
Understanding of the Mind-Brain. Cambridge, MA: MIT
Press; 2010:121-138.
Racine D, DuRousseau D, Illes J: Ethical issues in
performance-enhancing technologies: from bench to
headline.InNeurotechnology: Premises, Potential, and
Problems. Edited by James Giordano. Boca Raton: CRC
Press; 2012:175-198.
Russo MB, Stetz MC, Stetz TA: Ethical consider-
ations: cogniceuticals in the military. In Neuroethics
in Practice. Edited by Anjan Chatterjee, Martha J. Farah.
New York, NY: Oxford University Press; 2013:35-45.
Siipi H: Is neuroenhancement unnatural, and does
it morally matter? In Neurotechnology: Premises, Poten-
tial, and Problems. Edited by James Giordano. Boca
Raton: CRC Press; 2012:199-212.
Singh I, Kelleher K: The case for clinical manage-
ment of neuroenhancement in young people. In
Neuroethics in Practice. Edited by Anjan Chatterjee,
Martha J. Farah. New York, NY: Oxford University Press;
2013:16-34.
Terbeck S: Neuroethics of social enhancement.In
her The Social Neuroscience of Intergroup Relations:
Prejudice, Can We Cure It? New York: Springer;
2016:69-83.
Viirre E, Baylis F, Downie J: Promises and perils of
cognitive performance tools: a dialogue.InNeurotech-
nology: Premises, Potential, and Problems. Edited by
James Giordano. Boca Raton: CRC Press; 2012:125-141.
Ethical issues in neurology (including neuro-rehabilitation)
Articles:
Al-Delaimy WK: Ethical concepts and future chal-
lenges of neuroimaging: an Islamic perspective.Sci Eng
Ethics 2012, 18(3):509-518. doi:10.1007/s11948-012-9386-3
Andrews K: Medical decisionmaking in the vegeta-
tive state: withdrawal of nutrition and hydration.
NeuroRehabilitation 2004, 19(4):299-304.
Annas GJ: Culture of lifepolitics at the bedside -
the case of Terri Schiavo.N Engl J Med 2005,
352(16):1710-1715. doi:10.1056/NEJMlim050643.
Aricò I et al.: Could combined sleep and pain evalu-
ation be useful in the diagnosis of disorders of
Becker et al. Philosophy, Ethics, and Humanities in Medicine (2017) 12:1 Page 8 of 32
consciousness (DOC)? preliminary findings.Brain Inj
2016, 30(2):159-163. doi: 10.3109/02699052.2015.1089595.
Baars BJ, Ramsøy TZ, Laureys S: Brain, conscious ex-
perience and the observing self. Trends Neurosci 2003,
26(12):671-675. doi:10.1016/j.tins.2003.09.015.
Bardin JC et al.: Dissociations between behavioural and
functional magnetic resonance imaging-based evalua-
tions of cognitive function after brain injury.Brain 2011,
134(Pt 3): 769-782. doi: 10.1093/brain/awr005.
Bender A et al.: Persistent vegetative state and min-
imally conscious state: a systematic review and meta-
analysis of diagnostic procedures. Dtsch Arztebl Int
2015, 112(14):235-242. doi:10.3238/arztebl.2015.0235.
Bernat JL: The biophilosophical basis of whole-
brain death.Soc Philos Policy 2002, 19(2): 324-342.
doi:10.1017/S0265052502192132.
Brogan ME, Provencio JJ: Spectrum of catastrophic
brain injury: coma and related disorders of conscious-
ness. J Crit Care 2014, 29(4):679-682. doi:10.1016/
j.jcrc.2014.04.014.
Brosnan C, Cribb A, Wainwright SP, Williams C:
Neuroscientists' everyday experiences of ethics: the
interplay of regulatory, professional, personal and
tangible ethical spheres.Sociol Health Illn 2013,
35(8):1133-1148. doi:10.1111/1467-9566.12026.
Calabrò RS et al.: End-of-life decisions in chronic
disorders of consciousness: sacrality and dignity as fac-
tors.Neuroethics 2016, 9(1):85-102. doi:10.1007/s12152-
016-9257-8.
Clausen J: Moving minds: ethical aspects of neural
motor prostheses.Biotechnol J 2008, 3(12):1493-1501.
doi:10.1002/biot.200800244.
Comte A et al.: On the difficulty to communicate with
fMRI-based protocols used to identify covert aware-
ness.Neuroscience 2015, 300:448-459. doi:10.1016/
j.neuroscience.2015.05.059.
Conrad G, Sinha P: Scintigraphy as a confirmatory
test of brain death.Semin Nucl Med 2003, 33(4):312-
323. doi:10.1016/S0001-2998(03)00034-5.
Cranford R: Facts, lies, and videotapes: the perman-
ent vegetative state and the sad case of Terri Schiavo.
J Law Med Ethics 2005, 33(2):363-371. doi:10.1111/
j.1748-720X.2005.tb00501.x.
Crozier S: Neuroéthique: questions éthiques en
neurosciences [neuroethics: ethical issues in neuro-
sciences].Rev Prat 2013, 63(5):666-669.
Deeb W et al.: Proceedings of the Fourth Annual
Deep Brain Stimulation Think Tank: a review of
emerging issues and technologies.Front Integr
Neurosci 2016, 10:38. doi:10.3389/fnint.2016.00038.
Demetriades AK, Demetriades CK, Watts C, Ashkan
K: Brain-machine interface: the challenge of
neuroethics.Surgeon 2010, 8(5):267-269. doi:10.1016/
j.surge.2010.05.006.
Farah MJ: An ethics toolbox for neurotechnology.
Neuron 2015, 86(1):34-37. doi:10.1016/j.neuron.2015.03.038.
Farah MJ: Neuroethics and the problem of other
minds: implications of neuroscience evidence for the
moral status of brain-damaged patients and nonhu-
man animals.Neuroethics 2008, 1(1):9-18. doi:10.1007/
s12152-008-9006-8.
Farah MJ, Heberlein AS: Personhood and neurosci-
ence: naturalizing or nihiliating? Am J Bioeth 2007,
7(1):37-48. doi:10.1080/15265160601064199.
Farisco M, Petrini C: Misdiagnosis as an ethical and
scientific challenge. Ann Ist Super Sanita 2014,
50(3):229-233. doi:10.4415/ANN_14_03_05.
Figueroa G: Neuroética: reflexiones sobre los princi-
pios de la moral latentes en la medicina [neuroethics:
reflections on the latent principles of morals in medi-
cine].Rev Med Chil 2012, 140(8):1078-1084.
doi:10.4067/S0034-98872012000800018.
Fins JJ: Clinical pragmatism and the care of brain
damaged patients: toward a palliative neuroethics for
disorders of consciousness. Prog Brain Res 2005,
150:565-582. doi:10.1016/S0079-6123(05)50040-2.
Fins JJ: Lessons from the injured brain: a bioethicist
in the vineyards of neuroscience.Camb Q Healthc
Ethics 2009, 18(1):7-13. doi:10.1017/S0963180108090038.
Fins JJ et al. Neuroimaging and disorders of con-
sciousness: envisioning an ethical research agenda.Am
J Bioeth 2008, 8(9):3-12. doi:10.1080/15265160802318113.
Fins JJ: Nanotechnology, neuromodulation & the
immune response: discourse, materiality & ethics.
Biomed Microdevices 2015, 17(2):28. doi:10.1007/
s10544-015-9934-0.
Fins JJ, Schiff ND: Shades of gray: new insights into
the vegetative state.Hastings Cent Rep 2006, 36(6):8.
doi:10.1353/hcr.2006.0094.
Ford PJ, Deshpande A: The ethics of surgically
invasive neuroscience research.Handb Clin Neurol
2013, 118:315-321. doi:10.1016/B978-0-444-53501-
6.00026-3.
Gabriel D et al.: Replicability and impact of statistics
in the detection of neural responses of consciousness.
Brain 2016, 139(Pt 6):e30. doi:10.1093/brain/aww065.
Gassen HG: Why neuroethics? Biotechnol J 2008,
3(12):1463-1465. doi:10.1002/biot.200890109.
Giacino JT et al.: The minimally conscious state:
definition and diagnostic criteria. Neurology 2002,
58(3):349-353. doi:10.1212/WNL.58.3.349.
Giordano J: Conditions for consent to the use of neu-
rotechnology: a preparatory neuroethical approach to
risk assessment and reduction.AJOB Neurosci 2015,
6(4):12-49. doi:10.1080/21507740.2015.1094557.
Giordano J, Akhouri R, McBride DK: Implantable
nano-neurotechnological devices: consideration of eth-
ical, legal and social issues and implications. JLong
Becker et al. Philosophy, Ethics, and Humanities in Medicine (2017) 12:1 Page 9 of 32
Term Eff Med Implants 2009, 19(1):83-93. doi:10.1615/
JLongTermEffMedImplants.v19.i1.80.
Giordano J: A preparatory neuroethical approach
to assessing developments in neurotechnology.
AMA J Ethics 2015, 17(1):56-61. doi:10.1001/virtual-
mentor.2015.17.01.msoc1-1501.
Giordano J. Toward an operational neuroethical risk
analysis and mitigation paradigm for emerging neuro-
science and technology (neuroS/T).Exp Neurol 2016,
287(4):492-495. doi:10.1016/j.expneurol.2016.07.016.
Giordano J: The value of patient benefit: consider-
ation of framing contingencies to guide the ethical
use of DBSa case analysis.Camb Q Healthc Ethics
2016, 25(4):755-758. doi:10.1017/S0963180116000530.
Gostin LO: Ethics, the constitution, and the dying
process: the case of Theresa Marie Schiavo. JAMA
2005, 293(19):2403-2407. doi:10.1001/jama.293.19.2403.
Green RM: Neural technologies: the ethics of intim-
ate access to the mind.Hastings Cent Rep 2015,
45(6):36-37. doi:10.1002/hast.516.
Greenspan RJ: Biological indeterminacy.Sci Eng Eth-
ics 2012, 18(3):447-452. doi:10.1007/s11948-012-9379-2.
Harris J, Lawrence DR: Hot baths and cold minds:
neuroscience, mind reading, and mind misreading.
Camb Q Healthc Ethics 2015, 24(2):123-134.
doi:10.1017/S0963180114000425.
Haubenberger D, Clifford DB: Clinical trials in
neurovirology: successes, challenges, and pitfalls.
Neurotherapeutics 2016, 13(3):571-581. doi:10.1007/
s13311-016-0440-8.
Illes J: Empirical neuroethics: can brain imaging
visualize human thought? why is neuroethics inter-
ested in such a possibility.EMBO Rep 2007, 8:S57-S60.
doi:10.1038/sj.embor.7401007.
Iosa M, Morone G, Cherubini A, Paolucci S: The
three laws of neurorobotics: a review on what neuror-
ehabilitation robots should do for patients and clini-
cians.J Med Biol Eng 2016, 36:1-11. doi:10.1007/
s40846-016-0115-2.
Jennett B: The assessment and rehabilitation of
vegetative and minimally conscious patients: defi-
nitions, diagnosis, prevalence and ethics. Neuro-
psychological Rehabilitation 2005, 15(3-4):163-165.
doi:10.1080/09602010443000632.
Jox RJ, Schöne-Seifert B, Brukamp K: Aktuelle kon-
troversen in der neuroethik [current controversies in
neuroethics].Nervenarzt 2013, 84(10):1163-1164.
doi:10.1007/s00115-013-3731-x.
Jox RJ: Beste interessen im "vegetativen zustand"
[best interests in the 'vegetative state'].Fortschr
Neurol Psychiatr 2011, 79(10):576-581. doi:10.1055/s-
0031-1281736.
Jox RJ et al.: Diagnosis and decision making for pa-
tients with disorders of consciousness: a survey
among family members.Arch Phys Med Rehabil 2015,
96(2):323-330. doi: 10.1016/j.apmr.2014.09.030.
Jox RJ, Bernat JL, Laureys, Racine E: Disorders of con-
sciousness: responding to requests for novel diagnostic
and therapeutic interventions. Lancet Neurol 2012,
11(8):732-738. doi: 10.1016/S1474-4422(12)70154-0.
Kawashima K: 末期のケアとにおける
える [thinking about the best life in
end-of-life care and neuroethics].Rinsho Shinkeigaku
2008, 48(11):955-957.
Kontsevenko AS: Биoэтичecкиeпpoблeмы в
нeйpoбиoлoгии [bioethical problems in neurosciences].
Zh Nevrol Psikhiatr Im S S Korsakova 2011, 111(4):67-70.
Krug H: Neuroethik in der klinischen praxis
[Neuroethics in clinical practice].Nervenarzt 2009,
80(8):941-947. doi:10.1007/s00115-009-2683-7.
Kuehlmeyer K et al.: Physicians' attitudes toward
medical and ethical challenges for patients in the
vegetative state: comparing Canadian and German
perspectives in a vignette survey. BMC Neurol 2014,
14:119. doi:10.1186/1471-2377-14-119.
Kushner T, Giordano J: Clinical neuroethics from
bench to bedsideand beyond.Camb Q Healthc Ethics
2016, 25(4):570-572. doi:10.1017/S096318011600030X.
Lanfermann H, Schober O: Imaging of irreversible
loss of brain function.Röfo 2016, 188(1):23-26.
doi:10.1055/s-0041-108202.
Latronico N, Manenti O, Baini L, Rasulo FA: Quality
of reporting on the vegetative state in Italian newspa-
pers: the case of Eluana Englaro.PLoS One 2011,
6(4):e18706. doi:10.1371/journal.pone.0018706.
Laureys S: The neural correlate of (un)awareness:
lessons from the vegetative states. Trends Cogn Sci
2005, 9(12):556-559. doi:10.1016/j.tics.2005.10.010.
Laureys S et al.: Cerebral processing in the minim-
ally conscious state.Neurology 2004, 63(5): 916-918.
doi:10.1212/01.WNL.0000137421.30792.9B.
Lee G et al.: Canadian perspectives on the clinical
actionability of neuroimaging in disorders of con-
sciousness.Can J Neurol Sci 2015, 42(2):96-105.
doi:10.1017/cjn.2015.8.
Leshner AL: Ethical issues in taking neuroscience re-
search from bench to bedside.Cerebrum 2004, 6(4):66-72.
McMillan TM, Herbert CM: Further recovery in a
potential treatment withdrawal case 10 years after
brain injury.Brain Inj 2004, 18(9):935-940. doi:10.1080/
02699050410001675915.
Mikulis D, Weijer C, Young GB: Illuminating aware-
ness: implications of fMRI research in disorders of
consciousness.Can J Neurol Sci 2015, 42(4):211-212.
doi:10.1017/cjn.2015.34.
Miller FG, Kaptchuk TJ: Deception of subjects in
neuroscience: an ethical analysis.JNeurosci2008,
28(19):4841-4843. doi:10.1523/JNEUROSCI.1493-08.2008.
Becker et al. Philosophy, Ethics, and Humanities in Medicine (2017) 12:1 Page 10 of 32
Moosa E: Translating neuroethics: reflections from
Muslim ethics: commentary on "Ethical concepts and
future challenges of neuroimaging: an islamic per-
spective".Sci Eng Ethics 2012, 18(3):519-528.
doi:10.1007/s11948-012-9392-5.
Niebrój LT: Neuroetyki: nowa jakość etyki lekars-
kiej? [Neuroethics: new quality of medical ethics?]
Ann Acad Med Stetin 2013, 59(1):130-136.
Northoff G: Methodische defizite in der neuroethik:
brauchen wir theoretische neuroethik? [methodo-
logical deficits in neuroethics: do we need theoretical
neuroethics?] Nervenarzt 2013, 84(10):1196-1202.
doi:10.1007/s00115-013-3732-9.
Owen AM, Coleman MR: Detecting awareness in the
vegetative state. Ann N Y Acad Sci 2008, 1129:130-138.
doi:10.1196/annals.1417.018.
Parker LS, Kienholz ML: Disclosure issues in neuro-
science research.Account Res 2008, 15(4):226-241.
doi:10.1080/08989620802388697.
Peterson A et al.: Risk, diagnostic error, and the
clinical science of consciousness. Neuroimage Clin
2015, 7:588-597. doi:10.1016/j.nicl.2015.02.008.
Pierce R: What a tangled web we weave: ethical and
legal implications of deception in recruitment.Account
Res 2008, 15(4):262-282. doi:10.1080/08989620802388713.
Pirruccello A: Reductionism, brain imaging, and
social identity: commentary on biological indetermin-
acy.Sci Eng Ethics 2012, 18(3):453-456. doi:10.1007/
s11948-012-9372-9.
Pope John Paul II: Address of Pope John Paul II to
the participants in the International Congress on
life-sustaining treatments and vegetative state:
scientific advances and ethical dilemmas.NeuroReh-
abilitation 2004, 19(4):273-275.
Quill TE: Terri Schiavoa tragedy compounded.NEngl
JMed2005, 352(16):1630-1633. doi:10.1056/NEJMp058062.
Racine E et al.: Proven or unproven? panel report on
ethics in the translation of neuroscience.Can J Neurol
Sci 2012, 39(2):247-250. doi:10.1017/S0317167100013330.
Rady MY, Verheijde JL: Neuroscience and awareness
in the dying human brain: implications for organ
donation practices. J Crit Care 2016, 34:121-123. doi:
10.1016/j.jcrc.2016.04.016.
Robles del Olmo B, Garcia Collado D: [Ethical chal-
lenges of the finding of covert awareness with neuro-
imaging in vegetative states.] Med Clin (Barc) 2016,
146(5):218-222. doi: 10.1016/j.medcli.2015.07.011.
Rossi PJ et al.: Decision technologies in medical re-
search and practice: Practical considerations, ethical
implications and the need for dialectical evaluation.
Ethics Biol Eng Med 2013, 4(2):91-102. doi:10.1615/
EthicsBiologyEngMed.2013008091.
Rossi PJ, Giordano J, Walter BL, Okun MS: Ethical con-
siderations of broadcasting awake brain stimulation
surgery: reigniting a debate.Brain Stimul 2016,
9(3):320-322. doi:10.1016/j.brs.2016.03.012.
Rossi PJ et al.: Proceedings of the Third Annual
Deep Brain Stimulation Think Tank: a review of
emerging issues and technologies.Front Neurosci
2016, 10(119). doi:10.3389/fnins.2016.00119.
Rossi PJ, Okun M, Giordano J: Translational impera-
tives in deep brain stimulation research: addressing
neuroethical issues of consequences and continuity
of clinical care. AJOB Neurosci 2014, 5(1): 46-48.
doi:0.1080/21507740.2013.863248.
Saposnik G, Maurino J, Saizar R, Bueri JA: Spontaneous
and reflex movements in 107 patients with brain
death.Am J Med 2005, 118(3):311-314. doi:10.1016/
j.amjmed.2004.09.013.
Schiff ND et al.: fMRI reveals large-scale network acti-
vation in minimally conscious patients. Neurology 2005,
64(3):514-523. doi:10.1212/01.WNL.0000150883.10285.44.
Schiff ND et al.: Residual cerebral activity and
behavioural fragments can remain in the persistently
vegetative brain.Brain 2002, 125(Pt.6):1210-1234.
doi:10.1093/brain/awf131.
Schorr B, Schlee W, Arndt M, Bender A: Coherence
in resting-state EEG as a predictor for the recovery
from unresponsive wakefulness syndrome. J Neurol
2016, 263(5):937-953. doi: 10.1007/s00415-016-8084-5.
Smart CM, Giacino JT: Exploring caregivers' know-
ledge of and receptivity toward novel diagnostic tests
and treatments for persons with post-traumatic
disorders of consciousness. NeuroRehabilitation 2015,
37(1):117-130. doi:10.3233/NRE-151244.
Trimper JB, Wolpe PR, Rommelfanger KS: When I
becomes we: ethical implications of emerging
brain-to-brain interfacing technologies.Front Neu-
roeng 2014, 7:4. doi:10.3389/fneng.2014.00004.
Van McCrary S: Transferring emerging neuroscience
to the clinical ethics bedside.Am J Bioeth 2009,
9(9):21-23. doi:10.1080/15265160903098549.
Veatch RM: Abandon the dead donor rule or
change the definition of death? Kennedy Inst Ethics J
2004, 14(3):261-276. doi:10.1353/ken.2004.0035.
Venturelli AN, Branca I: Evidencia y neurociencias
cognitivas: el caso de la resonancia magnética funcio-
nal [evidence and cognitive neurosciences: the case
of functional MRI].Tópicos 2016, 50:177-207.
Wolpe PR: Ethical and social challenges of brain-
computer interfaces.Virtual Mentor 2007, 9(2):128-131.
doi:10.1001/virtualmentor.2007.9.2.msoc1-0702.
Books:
Ackerman S: Hard Science, Hard Choices: Facts,
Ethics, and Policies Guiding Brain Science Today. New
York: Dana Press; 2006.
Bernat JL, Beresford HR: Ethical and Legal Issues in
Neurology. Edinburgh: Elsevier; 2013.
Becker et al. Philosophy, Ethics, and Humanities in Medicine (2017) 12:1 Page 11 of 32
Giordano JJ, Gordijn B: Scientific and Philosophical
Perspectives in Neuroethics. Cambridge: Cambridge
University Press; 2010.
Glannon W: Defining Right and Wrong in Brain Sci-
ence: Essential Readings in Neuroethics. New York: Dana
Press; 2007.
Jennett B: The Vegetative State. Medical Facts, Ethical
And Legal Dilemmas. Cambridge: Cambridge University
Press; 2002.
Jox RJ, International Neuroethics Workshop for
Young Academics and Health Care Practitioners.
Vegetative State - A Paradigmatic Problem of Modern
Society: Medical, Ethical, Legal and Social Perspectives
on Chronic Disorders of Consciousness. Wein: Lit-Verl;
2012.
Laureys S, Tononi G: The Neurology of Consciousness:
Cognitive Neuroscience and Neuropathology. London:
Academic; 2009.
Lavazza A: Frontiers in Neuroethics: Conceptual and Em-
pirical Advancements. Newcastle upon Tyne: Cambridge
Scholars Publishing; 2016.
Shevell MI: Ethical Issues in Pediatric Neurology.
Philadelphia: Saunders; 2002.
Sinnott-Armstrong W: Finding Consciousness: The
Neuroscience, Ethics, and Law of Severe Brain Damage.
New York: Oxford University Press; 2016.
Williams MA, McGuire D, Rizzo M: Practical Ethics
in Clinical Neurology: A Case-based Learning Approach.
Philadelphia: Lippincott Williams & Wilkins; 2012.
Book Chapters:
Balaban CD: Neurotechnology and operational
medicine.InNeurotechnology in National Security and
Defense: Practical Considerations, Neuroethical Con-
cerns. Edited by James Giordano. Boca Raton: CRC
Press; 2015:65-78.
Bernat JL: Consciousness and death: the whole-
brain formulation of death.InFinding Consciousness:
The Neuroscience, Ethics, and Law of Severe Brain
Damage. Edited by Walter Sinnott-Armstrong. New
York: Oxford University Press; 2016:38-56.
Farah MJ: Personhood, consciousness, and severe
brain damage. In Neuroethics in Practice. Edited by
Anjan Chatterjee, Martha J. Farah. New York, NY:
Oxford University Press; 2013: 175-188.
Fins JJ, Schiff ND: Disorders of consciousness fol-
lowing severe brain injury. In Neuroethics in Practice.
Edited by Anjan Chatterjee, Martha J. Farah. New York,
NY: Oxford University Press; 2013:162-174.
Glannon W: Brain death. In his Bioethics and the
Brain. New York, NY: Oxford University Press;
2007:148-178.
Hawkins J: What is good for them? Best interests
and severe disorders of consciousness.InFinding Con-
sciousness: The Neuroscience, Ethics, and Law of Severe
Brain Damage. Edited by Walter Sinnott-Armstrong.
New York: Oxford University Press; 2016:180-206.
Laureys S: Brain Death. In Neuroethics in Practice.
Edited by Anjan Chatterjee, Martha J. Farah. New York,
NY: Oxford University Press; 2013:149-161.
Leshner AI: Ethical issues in taking neuroscience
research from bench to bedside.InDefining Right and
Wrong in Brain Science. Edited by Walter Glannon. New
York: Dana Press; 2007:75-82.
Owen AM, Naci L: Decoding thoughts in behavior-
ally nonresponsive patients.InFinding Consciousness:
The Neuroscience, Ethics, and Law of Severe Brain
Damage. Edited by Walter Sinnott-Armstrong. New
York: Oxford University Press; 2016:100-121.
Racine E: Communication of prognosis in disorders
of consciousness and severe brain injury: a closer look
at paradoxical discourses in the clinical and public
domains. In his Pragmatic Neuroethics. Cambridge, MA:
MIT Press; 2010:161-178.
Verheijde JL: Evidence and ethics.InEvidence-based
Neurology: Management of Neurological Disorders. Edi-
ted by Bart M. Demaerschalk, Dean M. Wingerchuk.
West Sussex, UK: Wiley Blackwell; 2015:13-20.
Ethical issues in psychiatry (including gender and LGBT)
Alpert S: The SPECTer of commercial neuroimaging.
AJOB Neurosci 2012, 3(4):56-58. doi:10.1080/
21507740.2012.721450.
Anderson JA, Illes J: Neuroimaging and mental
health: drowning in a sea of acrimony.AJOB Neurosci
2012, 3(4):42-43. doi:10.1080/21507740.2012.721454.
Appelbaum PS: Ethical challenges in the primary
prevention of schizophrenia. Schizophr Bull 2015,
41(4):773-775. doi:10.1093/schbul/sbv053.
Armon E, Kohls NB, Giordano J: On the viability of
neurotechnology and mind-body methods in pediatric
mental health: perspectives on integrating new tools to
complement old techniques.Eur J Integ Med 2016,
8(2):137-140. doi:10.1016/j.eujim.2015.12.011.
Barry LK: Ethical issues in psychiatric research.Psy-
chiatr Clin North Am 2009, 32(2):381-394. doi:10.1016/
j.psc.2009.02.003.
Baylis F, Downie J: Drilling down in neuroethics.Bioeth-
ics 2009, 23(6):iii-iv. doi:10.1111/j.1467-8519.2009.01730.x.
Belitz J, Bailey RA: Clinical ethics for the treatment
of children and adolescents: a guide for general psy-
chiatrists.Psychiatr Clin North Am 2009, 32(2):243-257.
doi:10.1016/j.psc.2009.02.001.
Bell JA: Preventing post-traumatic stress disorder
or pathologizing bad memories? Am J Bioeth 2007,
7(9): 29-30. doi:10.1080/15265160701518540.
Bikson M, Bhaskar P, Giordano J: The off-label use,
utility and potential value of tDCS in the clinical care
Becker et al. Philosophy, Ethics, and Humanities in Medicine (2017) 12:1 Page 12 of 32
of particular neuropsychiatric conditions.J Law Biosci
2016, 3(3):642-646. doi:10.1093/jlb/lsw044.
Bloch S, Green S: An ethical framework for psychiatry.
Br J Psychiatry 2006, 188:7-12. doi:10.1192/bjp.188.1.7.
Bockting WO: Vulnerability and resilience among
gender-nonconforming children and adolescents:
mental health professionals have a key role to play.J
Am Acad Child Adolesc Psychiatry 2016, 55(6):441-443.
doi:10.1016/j.jaac.2016.04.008.
Bott NT, Radke AE, Kiely T: Ethical issues surround-
ing psychologistsuse of neuroscience in the promo-
tion and practice of psychotherapy.Prof Psychol Res
Pr 2016, 47(5): 321-329. doi:10.1037/pro0000103.
Brown T: Narrative practice apart from truth.
AJOB Neurosci 2012, 3(4):91-92. doi:10.1080/
21507740.2012.722809.
Buchman DZ, Skinner W, Illes J: Negotiating the
relationship between addiction, ethics, and brain
science.AJOB Neurosci 2010, 1(1):36-45. doi:10.1080/
21507740903508609.
Cabral M et al.: Removal of gender incongruence of
childhood diagnostic category: a human rights
perspective.Lancet Psychiatry 2016, 3(5):405-406.
doi:10.1016/S2215-0366(16)30043-8.
Carpenter W: Diagnosing rather than labeling
young people with mental disorders: a response to
Mittal et al. Bioethics 2015, 29(9):683. doi:10.1111/
bioe.12179.
Carter A, Hall W: Beyond the right to injectable
heroin.AJOB Neurosci 2010, 1(1):48-49. doi:10.1080/
21507740903504467.
Charland LC: A madness for identity: psychiatric
labels, consumer autonomy, and the perils of the
internet.Philos Psychiatr Psychol 2004,11(4):335-349.
Chen DT, Shepherd LL: When, why, and how to con-
duct research in child and adolescent psychiatry: prac-
tical and ethical considerations.Psychiatr Clin North
Am 2009, 32(2):361-380. doi:10.1016/j.psc.2009.03.003.
Cheung EH: A new ethics of psychiatry: neuroethics,
neuroscience, and technology.J Psychiatr Pract 2009,
15(5):391-401. doi:10.1097/01.pra.0000361279.11210.14.
Coverdale J, Roberts LW: Global challenges and
ethics in protecting and promoting the interests of
psychiatrically ill patients. Int Rev Psychiatry 2010,
22(3):229-234. doi:10.3109/09540261.2010.486828.
Crane JK: Who you talkinabout?: parallel truthiness
concerns between autobiography and biography in
bioethics.AJOB Neurosci 2012, 3(4):82-83. doi:10.1080/
21507740.2012.721458.
Daley TC, Singhal N, Krishnamurthy V: Ethical
considerations in conducting research on autism
spectrum disorders in low and middle income coun-
tries. J Autism Dev Disord 2013, 43(9):2002-2014.
doi:10.1007/s10803-012-1750-2.
Dell ML: Child and adolescent depression: psycho-
therapeutic, ethical, and related nonpharmacologic
considerations for general psychiatrists and others
who prescribe. Psychiatr Clin North Am 2012,
35(1):181-201. doi:10.1016/j.psc.2011.12.002.
Diamond M: Developmental, sexual and reproduct-
ive neuroendocrinology: historical, clinical and eth-
ical considerations.Front Neuroendocrinol 2011,
32(2):255-263. doi:10.1016/j.yfrne.2011.02.003.
Drescher J, Cohen-Kettenis PT, Reed GM: Gender
incongruence of childhood in the ICD-11: controver-
sies, proposal, and rationale.Lancet Psychiatry 2016,
3(3):297-304. doi:10.1016/S2215-0366(15)00586-6.
Drescher J. Queer diagnoses: parallels and contrasts
in the history of homosexuality, gender variance,
and the Diagnostic and Statistical Manual.Arch Sex
Behav 2010, 39(2):427-460. doi:10.1007/s10508-009-
9531-5.
Drescher J: Queer diagnoses revisited: the past and
future of homosexuality and gender diagnoses in
DSM and ICD.Int Rev Psychiatry 2015, 27(5):386-395.
doi:10.3109/09540261.2015.1053847.
Farah MJ, Wolpe PR: Monitoring and manipulating
brain function: new neuroscience technologies and
their ethical implications.Hastings Cent Rep 2004,
34(3):35-45.
Farah MJ, Gillihan SJ: The puzzle of neuroimaging
and psychiatric diagnosis: technology and nosology in
an evolving discipline.AJOB Neurosci 2012, 3(4):31-41.
doi:10.1080/21507740.2012.713072.
Fisher CE: Neuroimaging and validity in psychiatric
diagnosis.AJOB Neurosci 2012, 3(4):50-51. doi:10.1080/
21507740.2012.721471.
Fitzpatrick SJ: The telling moment: narrative as a
discursive act.AJOB Neurosci 2012, 3(4):80-81.
doi:10.1080/21507740.2012.721452.
Fuchs T: Ethical issues in neuroscience.Curr
Opin Psychiatry 2006, 19(6):600-607. doi:10.1097/
01.yco.0000245752.75879.26.
Gibson S, Benson O, Brand SL: Talking about
suicide: confidentiality and anonymity in qualitative
research.Nurs Ethics 2013, 20(1):18-29. doi:10.1177/
0969733012452684.
Gillett GR: The subjective brain, identity, and neu-
roethics.Am J Bioeth 2009, 9(9):5-13. doi:10.1080/
15265160903090058.
Giordano J: On the implications of changing con-
structs of pain and addiction disorders in the DSM-5:
language games, ethics and action. IJLHE 2011, 7(1):1-8.
Giordano J: Neuroimaging in psychiatry: approaching
the puzzle as a piece of the bigger picture(s).AJOB Neu-
rosci 2012, 3(4):54-56. doi:10.1080/21507740.2012.721469.
Greely HT: Direct brain interventions to treatdis-
favored human behaviors: ethical and social issues.
Becker et al. Philosophy, Ethics, and Humanities in Medicine (2017) 12:1 Page 13 of 32
Clin Pharmacol Ther 2012, 91(2):163-165. doi:10.1038/
clpt.2011.292.
Greenberg D, Strous RD: Ethics and the psychiatry
journal editor: responsibilities and dilemmas. Isr J
Psychiatry Relat Sci 2014, 51(3):204-210.
Gupta M: Does evidence-based medicine apply to
psychiatry? Theor Med Bioeth 2007, 28(2): 103-120.
doi:10.1007/s11017-007-9029-x.
Hall W: Feeling better than well.EMBO Rep 2004,
5(12):1105-1109. doi:10.1038/sj.embor.7400303.
Hens K, Peeters H, Dierickz K: The ethics of complex-
ity: genetics and autism, a literature review. Am J Med
Genet B Neuropsychiatr Genet 2016, 171B(3):305-316.
doi:10.1002/ajmg.b.32432.
Hoop JG, Smyth AC, Roberts LW: Ethical issues in
psychiatric research on children and adolescents.
Child Adolesc Psychiatr Clin N Am 2008, 17(1):127-148.
doi:10.1016/j.chc.2007.07.003.
Hoop JG, Spellecy R: Philosophical and ethical issues
at the forefront of neuroscience and genetics: an
overview for psychiatrists.Psychiatr Clin North Am
2009, 32(2):437-449. doi:10.1016/j.psc.2009.03.004.
Horwitz AV, Wakefield JC: Should screening for
depression among children and adolescents be deme-
dicalized? J Am Acad Child Adolesc Psychiatry 2009,
48(7):683-687. doi: 10.1097/CHI.0b013e3181a5e3ad.
Herrera-Ferrá K, Giordano J: Re-classifying recur-
rent violent behavior? considerations, caveats and
neuroethical concerns for psychiatry and social en-
gagement.Acta Psychopathol 2016, 2:1. doi:10.4172/
2469-6676.100032.
Jotterand F, Giordano J: Transcranial magnetic stimu-
lation, deep brain stimulation and personal identity:
ethical questions, and neuroethical approaches for
medical practice.Int Rev Psychiatry 2011, 23(5):476-485.
doi:10.3109/09540261.2011.616189.2011.616189.
Kalis A: Narrative truth and cases of delusion.
AJOB Neurosci 2012, 3(4):87-89. doi:10.1080/
21507740.2012.721457.
Katz CL, Lahey TP, Campbell HT: An ethical frame-
work for global psychiatry.Ann Glob Health 2014,
80(2):146-151. doi:10.1016/j.aogh.2014.04.002.
Koelch M, Fegert JM: Ethics in child and adoles-
cent psychiatric care: an international perspective.
Int Rev Psychiatry 2010, 22(3):258-266. doi:10.3109/
09540261.2010.485979.
Lavazza A: Erasing traumatic memories: when
context and social interests can outweigh personal
autonomy.Philos Ethics Humanit Med 2015,10:3.
doi:10.1186/s13010-014-0021-6.
Lee G: Ethical issues in behavioral neuroscience:
ethics of human research in behavioral neuroscience:
overview of Section II.Curr Top Behav Neurosci 2015,
19:135-136. doi:10.1007/7854_2014_343.
Lingiardi V, Nardelli N, Tripodi E: Reparative attitudes
of Italian psychologists toward lesbian and gay clients:
theoretical, clinical, and social implications.Prof Psy-
chol Res Pr 2015, 46(2):132-139. doi:10.1037/pro0000016.
Loi M: Normal functioning and public reason.Camb
Q Healthc Ethics 2013, 22(2):136-145. doi:10.1017/
S0963180112000515.
Matthews S, Kennett J: Lying, narrative, and truth
shareability.AJOB Neurosci 2012, 3(4):86-87. doi:10.1080/
21507740.2012.721468.
Mittal VA, Dean DJ, Mittal J, Saks ER: Ethical, legal,
and clinical considerations when disclosing a high-risk
syndrome for psychosis.Bioethics 2015, 29(8):543-556.
doi:10.1111/bioe.12155.
Mosley PE, Marsh R, Carter A: Deep brain stimula-
tion for depression: Unterrainer Mscientific issues
and future directions. Aust N Z J Psychiatry 2015, 4
(11):967-978. doi:10.1177/0004867415599845.
Northoff G: Neuroscience of decision making and in-
formed consent: an investigation in neuroethics.JMed
Ethics 2006, 32(2):70-73. doi:10.1136/jme.2005.011858.
Northoff G: What is neuroethics? empirical and
theoretical neuroethics.Curr Opin Psychiatry 2009,
22(6):565-569. doi:10.1097/YCO.0b013e32832e088b.
Parmigiani G et al.: Decisional capacity to consent to
clinical research involving placebo in psychiatric
patients. J Forensic Sci 2016, 61(2):388-393. doi:10.1111/
1556-4029.13000.
Patil T, Giordano J: On the ontological assumptions
of the medical model of psychiatry: philosophical
considerations and pragmatic tasks.Philos Ethics
Humanit Med 2010, 5:3. doi:10.1186/1747-5341-5-3.
Radden J: Notes towards a professional ethics for
psychiatry.Aust N Z J Psychiatry 2002, 36(1):52-59.
doi:10.1046/j.1440-1614.2002.00989.x.
Ramos RT: The conceptual limits of neuroimaging
in psychiatric diagnosis.AJOB Neurosci 2012, 3(4):52-
53. doi:10.1080/21507740.2012.721856.
Remschmidt H: Psychopharmacological treatments in
children and adolescents: adequate use or abuse? World
Psychiatry 2013, 12(2):135-136. doi:10.1002/wps.20036.
Rich BA: My story, my self: the pathologizing of
personal identity.AJOB Neurosci 2012, 3(4):89-91.
doi:10.1080/21507740.2012.721456.
Roskies AL: Neuroethics beyond genetics: despite the
overlap between the ethics of neuroscience and genet-
ics, there are important areas where the two diverge.
EMBO Rep 2007, 8:S52-S56. doi:10.1038/sj.embor.7401009.
Salles A: Neuroethics in a psyworld: the case of
Argentina.Camb Q Healthc Ethics 2014, 23(3):297-307.
doi:10.1017/S096318011300090X.
Sample M: Evolutionary, not revolutionary: current
prospects for diagnostic neuroimaging.AJOB Neurosci
2012, 3(4):46-48. doi:10.1080/21507740.2012.721461.
Becker et al. Philosophy, Ethics, and Humanities in Medicine (2017) 12:1 Page 14 of 32
Satel S, Lilienfeld SO: Singing the brain disease
blues.AJOB Neurosci 2010, 1(1):46-47. doi:10.1080/
21507740903504368.
Schechtman M: Making the truth: self-understanding,
self-constitution, neuroscience, and narrative.AJOB Neu-
rosci 2012, 3(4):75-76. doi:10.1080/21507740.2012.721453.
Song SJ: An ethical approach to life-long learning:
implications for global psychiatry. Acad Psychiatry
2011, 35(6):391-396. doi:10.1176/appi.ap.35.6.391.
Stier M, Muders S, Rüther M, Schöne-Seifert B:
Biologismus-kontroversen: ethische implikationen
für die psychiatrie [biologism controversy: ethical
implications for psychiatry].Nervenarzt 2013,
84(10):1165-1174. doi:10.1007/s00115-013-3736-5.
Strous RD: Ethical considerations in clinical training,
care and research in psychopharmacology.Int J Neurop-
sychopharmacol 2011, 14(3):413-424. doi:10.1017/
S1461145710001112.
Suárez Richards M: Psiquiatría y neuroética [psychiatry
and neuroethics].Vertex 2013, 24(109):233-240.
Synofzik M: Intervenieren in der neuronalen basis der
persönlichkeit: eine praxisorientierte ethische analyse
der neuropharmakologie und der tiefen hirnstimulation
[Intervening in the neural basis of one's personality: a
practice-oriented ethical analysis of neuropharmacology
and deep-brain stimulation].Dtsch Med Wochenschr
2007, 132(50):2711-2713. doi:10.1055/s-2007-993124.
Takagi M: としての
[safety and neuroethical consid-
eration of deep brain stimulation as a psychiatric
treatment].Brain Nerve 2009, 61(1):33-40.
Thachuk AK: Stigma and the politics of biomedical
models of mental illness. Int J Fem Approaches Bioeth
2011, 4(1):140-163. doi:10.2979/intjfemappbio.4.1.140.
Thong IS et al.: Therapeutic misconception in
psychiatry research: a systematic review. Clin Psycho-
pharmacol Neurosci 2016, 14(1):17-25. doi:10.9758/
cpn.2016.14.1.17.
Tsao CI, Layde JB, Roberts LW: A review of ethics in
psychiatric research.Curr Opin Psychiatry 2008,
21(6):572-577. doi:10.1097/YCO.0b013e32830aba23.
Umbach R, Berryessa CM, Raine A: Brain imaging
research on psychopathy: implications for punishment,
prediction, and treatment in youth and adults. J Crim
Jus 2015, 43(4):295-306. doi:10.1016/j.jcrimjus.2015.04.003.
Unterrainer M, Oduncu FS: The ethics of deep brain
stimulation (DBS). Med Health Care Philos 2015,
18(4):475-485. doi:10.1007/s11019-015-9622-0.
Van Niek erk AA: Biomedical enhancement and the
pursuit of mastery and perfection: a critique of the views
of Michael Sandel.SAfrJPhilos2014, 33(2):155-165.
Vaz M, Srinivasan K: Ethical challenges & dilemmas
for medical health professionals doing psychiatric
research. Indian J Med Res 2014, 139(2):191-193.
Vuilleumier P, Sander D, Baertschi B: Changing the
brain, changing the society: clinical and ethical im-
plications of neuromodulation techniques in neur-
ology and psychiatry.Brain Topogr 2014, 27(1):1-3.
doi:10.1007/s10548-013-0325-7.
Walker MJ: Neuroscience, self-understanding, and
narrative truth.AJOB Neurosci 2012, 3(4):63-74.
doi:10.1080/21507740.2012.712603.
Wolpe PR: Ethics and social policy in research on
the neuroscience of human sexuality.Nat Neurosci
2004, 7(10):1031-1033. doi:10.1038/nn1324.
Wright MT, Roberts LW: A basic decision-making
approach to common ethical issues in consultation-
liaison psychiatry.Psychiatr Clin North Am 2009,
32(2):315-328. doi:10.1016/j.psc.2009.03.001.
Wurzman R, Giordano J: Differential susceptibil-
ity to plasticity: a missing linkbetween gene-
culture coevolution and neuropsychiatric spectrum
disorders? BMC Med 2012, 10:37. doi:10.1186/1741-
7015-10-37.
Zohny H: Enhancement, disability and the riddle
of the relevant circumstances.JMedEthics2016,
42(9):605-610. doi:10.1136/medethics-2015-103229.
Books
Dogan H: MIS-UN-TRUE Informed Consent: Focus on
Informed Consent and Ethical Requirements for Clinical
Trials of Neuroscience and Psychiatry. Saarbrücken:
Lambert Academic Publishing; 2015.
Elliot C: Better Than Well: American Medicine Meets
the American Dream. New York: W.W.Norton; 2003.
Elliot C: Chambers T: Prozac as a Way of Life. Chapel
Hill, NC: University of North Carolina Press; 2004.
Fulford KWM, Thornton T, Graham G: Oxford Text-
book of Philosophy and Psychiatry. New York: Oxford
University Press; 2006.
Gupta M: Is Evidence-based Psychiatry Ethical?
Oxford: Oxford University Press; 2014.
Healy D: Let Them Eat Prozac: The Unhealthy
Relationship Between the Pharmaceutical Industry and
Depression. New York: New York University Press; 2004.
Lee G, Illes J, Ohl F: Ethical Issues in Behavioral
Neuroscience. Heidelberg: Springer; 2015.
Phillips J: Philosophical Perspectives on Technology
and Psychiatry. Oxford: Oxford University Press; 2009.
Sadler JZ, van Staden W, Fulford KWM: The Oxford
Handbook of Psychiatric Ethics. Oxford: Oxford University
Press; 2015.
Sahakian BJ, LaBuzetta JN: Bad Moves: How Decision
Making Goes Wrong, and the Ethics of Smart Drugs.
Oxford: Oxford University Press; 2013.
Book Chapters
Bluhm R, Raczek M, Broome, MR, Wall MB: Ethical
issues in brain imaging in psychiatry.InOxford Hand-
book of Psychiatric Ethics. Edited by John A. Sadler,
Becker et al. Philosophy, Ethics, and Humanities in Medicine (2017) 12:1 Page 15 of 32
Werdie van Staden, K.W.M. Fulford. Oxford: Oxford
University Press; 2015:1109-1125.
Conrad P, Horwitz A: Marketing of neuropsychiatric
illness and enhancement. In Neuroethics in Practice.
Edited by Anjan Chatterjee, Martha J. Farah. New York:
Oxford University Press; 2013:46-56.
Drescher J: Ethical issues in treating LGBT patients.
In Oxford Handbook of Psychiatric Ethics. Edited by John
A. Sadler, Werdie van Staden, K.W.M. Fulford. Oxford:
Oxford University Press; 2015:180-192.
Glannon W: Pharmacological and psychological
interventions. In his Bioethics and the Brain. New York:
Oxford University Press; 2007:76-115.
Glannon W: Psychiatric neuroethics I: deep brain
stimulation and lesioning.InOxford Handbook of
Psychiatric Ethics. Edited by John A. Sadler, Werdie van
Staden, K.W.M. Fulford. Oxford: Oxford University
Press; 2015:1191-1206.
Glannon W: Psychiatric neuroethics II: less invasive
and non-invasive techniques.InOxford Handbook of
Psychiatric Ethics. Edited by John A. Sadler, Werdie van
Staden, K.W.M. Fulford. Oxford: Oxford University
Press; 2015:1207-1227.
Hansen JL: A virtue-based approach to neuro-
enhancement in the context of psychiatric practice.
In Oxford Handbook of Psychiatric Ethics. Edited by John
A. Sadler, Werdie van Staden, K.W.M. Fulford. Oxford:
Oxford University Press; 2015:1228-1249.
Kleinbub JR, Zidarich S: Are near-death-experience
memories real? ethical implications of a neuro-
psychological study.InFrontiers in Neuroethics:
Conceptual and Empirical Advances. Edited by Andrea
Lavazza. Newcastle upon Tyne : Cambridge Scholars
Publishing; 2016:135-156.
Radden J: Virtue ethics as professional ethics; the
case of psychiatry.InWorking Virtue: Virtue Ethics and
Contemporary Moral Problems. New York: Oxford
University Press; 2007:113-134.
Ethical issues in anesthesiology/pain medicine (including
addiction)
Brenner GJ, Kueppenbender K, Mao J, Spike J: Ethical
challenges and interventional pain medicine. Curr
Pain Headache Rep 2012, 16(1):1-8. doi:10.1007/s11916-
011-0242-y.
Carter D, Sendziuk P, Eliott JA, Braunack-Mayer A:
Why is pain still under-treated in the emergency
department? two new hypotheses.Bioethics 2016,
30(3):195-202. doi:10.1111/bioe.12170.
Compagnone C, Tagliaferri F, Allegri M, Fanelli G:
Ethical issues in pain and omics research: some
points to start the debate.Croat Med J 2014, 55(1):1-2.
doi:10.3325/cmj.2014.55.1.
Compton P, Weaver MF: Responsible opioid use.J
Pain Palliat Care Pharmacother 2015, 29(2):166-168.
doi:10.3109/15360288.2015.1037522.
da Cunha BF: Ethics and undertreatment of pain in
patients with a history of drug abuse.Medsurg Nurs
2015, 24(1):Suppl 4-7, 16.
Demertzi A et al.: Pain perception in disorders of
consciousness: neuroscience, clinical care, and ethics
in dialogue.Neuroethics 2013, 6(1):37-50. doi:10.1007/
s12152-011-9149-x.
Franklin GM: Primum non nocere.Pain Med 2013,
14(5):617-618. doi:10.1111/pme.12120_2.
Garcia AM: State laws regulating prescribing of
controlled substances: balancing the public health
problems of chronic pain and prescription painkiller
abuse and overdose.J Law Med Ethics 2012, 41(Suppl
1):42-45. doi:10.1111/jlme.12037.
Giordano J: Cassandras curse: interventional pain
management, policy and preserving meaning against
a market mentality.Pain Physician 2006, 9(3):167-169.
Giordano J: Complementarity, brain-mind, and pain.
Forsch Komplementmed 2008, 15(2):71-73. doi:10.1159/
000121106.
Giordano J, Schatman ME: A crisis in chronic pain
care: an ethical analysis: part two: proposed structure
and function of an ethics of pain medicine. Pain Phys-
ician 2008, 11(5): 589-595.
Giordano J, Schatman ME: A crisis in chronic pain care:
an ethical analysis: part three: toward an integrative,
multi-disciplinary pain medicine built around the needs
of the patient. Pain Physician 2008, 11(6): 775-784.
Giordano J, Engebretson JC, Benedikter R: Culture,
subjectivity, and the ethics of patient-centered pain
care.Camb Q Healthc Ethics 2009, 18(1):47-56.
doi:10.1017/S0963180108090087.
Giordano J, Schatman ME: A ethical analysis of
crisis in chronic pain care: facts, issues and prob-
lems in pain medicine: part 1. Pain Physician 2008,
11(4):483-490.
Giordano J, Schatman ME, Höver G: Ethical insights
to rapprochement in pain care: bringing stakeholders
together in the best interest(s) of the patient. Pain
Physician 2009, 12(4):E265-E275.
Giordano J: Ethics of, and in, pain medicine:
constructs, content, and contexts of application. Pain
Physician 2008, 11(4):391-392.
Giordano J: Maldynia: chronic pain as illness, and the
need for complementarity in pain care.Forsch Komple-
mentmed 2008, 15(5):277-281. doi:10.1159/000158572.
Giordano J: Moral agency in pain medicine: philoso-
phy, practice and virtue. Pain Physician 2006, 9(1):41-46.
Giordano J: The neuroscience of pain, and a neu-
roethics of pain care. Neuroethics 2010, 3(1):89-94.
doi:10.1007/s12152-009-9034-z.
Becker et al. Philosophy, Ethics, and Humanities in Medicine (2017) 12:1 Page 16 of 32
Giordano J, Gomez CF, Harrison C: On the potential
role for interventional pain management in palliative
care. Pain Physician 2007, 10(3):395-398.
Giordano J: Pain and suffering: Körper and Leib,
and the telos of pain care.Philos Psychiatr Psychol
2013,19(4):279-283.
Giordano J, Abramson K, Boswell MV: Pain assess-
ment: subjectivity, objectivity, and the use of neuro-
technology. Pain Physician 2010, 13(4):305-315.
Giordano J, Schatman ME, Benedikter R: Pain care
for a global community: part 2: ethics and economics
in intersection.Pract Pain Manag 2008, 8(7):65-69.
Giordano J, Newman R, Boswell MV: Pain medicine,
biotechnology and market effects: tools, tekne and
moral responsibility.Ethics Biol Eng Med 2010, 1(2):133-
140. doi:10.1615/EthicsBiologyEngMed.v1.i2.50.
Giordano J, Boswell MV: Pain, placebo, and nocebo:
epistemic, ethical and practical issues.Pain Physician
2005, 8(4):331-333.
Giordano J: Pain research: can paradigmatic expan-
sion bridge the demands of medicine, scientific phil-
osophy and ethics? Pain Physician 2004, 7(4):407-410.
Giordano J, Kohls NB: Self, suffering and spirituality:
the neuroscience of being, pain and spiritual experi-
ences and practices.Mind Matter 2008, 6(2):179-191.
Giordano J: Techniques, technology, and tekne: on
the ethical use of guidelines in the practice of interven-
tional pain medicine. Pain Physician 2007, 10(1):1-5.
Giordano J, Benedikter R: The shifting architectonics
of pain medicine: toward ethical realignment of scien-
tific, medical and market values for the emerging glo-
bal communitygroundwork for policy. Pain Med 2011,
12(3):406-414. doi:10.1111/j.1526-4637.2011.01055.x.
Goldberg DS, Rich BA: Few benefits, likely harms:
against universal random urine drug screening in
pain management.Pain Med 2014, 15(12):2000-2001.
doi:10.1111/pme.12604_3.
Gupta A, Giordano J: On the nature, assessment,
and treatment of fetal pain: neurobiological bases,
pragmatic issues and ethical concerns.Pain Physician
2007, 10(4):525-532.
Heit HA: Healthcare professionals and the DEA: try-
ing to get back in balance.Pain Med 2006, 7(1):72-74.
doi:10.1111/j.1526-4637.2006.00093.x
Knight C, Albertsen A: Rawlsian justice and pallia-
tive care.Bioethics 2015, 29(8):536-542. doi:10.1111/
bioe.12156.
Kotalik J: Controlling pain and reducing misuse of
opioids: ethical considerations.Can Fam Physician
2012, 58(4):381-385.
Loveless SE, Giordano J: Neuroethics, painience, and
neurocentric criteria for the moral treatment of ani-
mals.Camb Q Healthc Ethics 2014, 23(2):163-172.
doi:10.1017/S0963180113000698.
Marcus BS, Venkat A: Ethical pain management in the
emergency department: the canary in the coal mine.
Pain Manag 2015, 5(4):251-260. doi:10.2217/pmt.15.18.
McConnell D, Snoek A: Narrating truths worth
living: addiction narratives.AJOB Neurosci 2012,
3(4):77-78. doi:10.1080/21507740.2012.721459.
McGrew M, Giordano J: Whence tendance? accept-
ing the responsibility of care for the chronic pain
patient.Pain Physician 2009, 12(3):483-485.
Niebrój LT, Jadamus-Niebrój D, Giordano J: Toward a
moral grounding of pain medicine: consideration of
neuroscience, reverence, beneficence, and autonomy.
Pain Physician 2008, 11(1):7-12.
Oliver J et al.: American Society for Pain Management
nursing position statement: pain management in
patients with substance use disorders.J Addict Nurs
2012, 23(3):210-222. doi:10.1097/JAN.0b013e318271c123.
Olsen DP: Ethical practice with patients in pain.
Am J Nurs 2016, 116(1):57-60. doi:10.1097/
01.NAJ.0000476172.74165.1c.
Payne R et al.: A rose by any other name: pain
contracts/agreements.Am J Bioeth 2010, 10(11):5-12.
doi:10.1080/15265161.2010.519425.
Pentin PL: Drug seeking or pain crisis? responsible
prescribing of opioids in the emergency department.
Virtual Mentor 2013, 15(5):410-415. doi:10.1001/virtual-
mentor.2013.15.5.ecas2-1305.
Peppin J: Preserving beneficence.Pain Med 2013,
14(5):619. doi:10.1111/pme.12120_3.
Riganello F et al.: Pain perception in unresponsive
wakefulness syndrome may challenge the interruption of
artificial nutrition and hydration: neuroethics in action.
Front Neurol 2016, 7:202. doi:10.3389/fneur.2016.00202.
Robinson PJ, Rickard JA: Ethical quandaries in car-
ing for primary-care patients with chronic pain.Fam
Syst Health 2013, 31(1):52-59. doi:10.1037/a0031952.
Robinson-Papp J, George MC: Trust and the ethics of
chronic pain management in HIV.J Assoc Nurses AIDS
Care 2015, 26(5):509-513. doi:10.1016/j.jana.2015.05.007.
Venkat A et al.: An ethical framework for the man-
agement of pain in the emergency department. Acad
Emerg Med 2013, 20(7):716-723. doi:10.1111/acem.12158.
Books:
Benasayag M, Abtroun S: L'éthique de la Souffrance
[the ethics of suffering]. Latresne: Bord de l'eau; 2002.
Bruder N, Bissonnette B, Ravussin P: La Réanimation
Neurochirurgicale [Neurosurgical Resuscitation]. Paris:
Springer; 2007.
Buonocore G, Bellieni CV: Neonatal Pain: Suffering,
Pain and Risk of Brain Damage in the Fetus and
Newborn. Milano: Springer-Verlag Italia; 2008.
Caenepeel D: La Sédation Continue en Fin de Vie:
Enjeux Ethiques [Sedation at the End of Life: Ethical
Issues]. Montréal: Médiaspaul; 2005.
Becker et al. Philosophy, Ethics, and Humanities in Medicine (2017) 12:1 Page 17 of 32
Carter A, Hall W, Illes J: Addiction Neuroethics: The
Ethics of Addiction Neuroscience Research and Treat-
ment. London: Academic Press; 2012.
Cole BE: Ethics in Pain Management and End-of-Life
Care. Glendale, CA: Audio-Digest Foundation; 2006.
Gallagher RM: Insight and Responsibility: Ethics in
Pain Medicine and Palliative Care. London: Henry
Stewart Talks; 2009.
George SK, Jung PG: Cultural Ontology of the Self in
Pain. New Delhi: Springer; 2016.
Giordano J: Maldynia: Multidisciplinary Perspectives on
the Illness of Chronic Pain. Boca Raton, FL: CRC Press; 2011.
Giordano JJ, Boswell MV: Pain Medicine: Philosophy,
Ethics and Policy. Chicago: Linton Atlantic Books; 2009.
Giordano JJ: Pain: Mind, Meaning, and Medicine:
Collected Essays on the Philosophical and Ethical
Dimensions of Practical Pain Management. Glen Mills,
PA: PPM Communications, Inc.; 2009.
Goldberg DS: The Bioethics of Pain Management:
Beyond Opioids. New York: Routledge; 2014.
Green RM, Palpant NJ: Suffering and Bioethics.Oxford:
Oxford University Press; 2014.
Grønstad A, Gustafsson H: Ethics and Images of Pain.
New York: Routledge; 2012.
Husebø S, Klaschik E: Palliativmedizin [Palliative
Medicine]. Berlin: Springer; 2009.
Loland S, Skirstad B, Waddington I: Pain and Injury in
Sport: Social and Ethical Analysis. London: Routledge; 2006.
Meldrum M: Opioids and Pain Relief: A Historical
Perspective. Seattle: IASP Press; 2003.
Morrissey MBQ: Suffering Narratives of Older Adults: A
Phenomenological Approach to Serious Illness, Chronic Pain,
Recovery and Maternal Care. New York: Routledge; 2015.
Schatman ME: Ethical Issues in Chronic Pain Manage-
ment. New York: Informa Healthcare; 2007.
Schopenhauer A, Hollingdale RJ: On the Suffering of
the World. London: Penguin Books; 2004.
van Norman GA, Jackson S, Rosenbaum SH, Palmer
SK: Clinical Ethics in Anesthesiology: A Case-Based
Textbook. New York: Cambridge University Press; 2011.
Book Chapters:
Giordano J: From a neurophilosophy of pain to a
neuroethics of pain care. In Scientific and Philosophical
Perspectives in Neuroethics. Edited by James J. Giordano,
Bert Gordijn. New York: Cambridge University Press;
2010:172-189.
Hardcastle VG: Minimally conscious states and pain:
a different approach to patient ethics.InFinding Con-
sciousness: The Neuroscience, Ethics, and Law of Severe
Brain Damage. Edited by Walter Sinnott-Armstrong.
New York: Oxford University Press; 2016:207-225.
Hyman SE: Addiction and responsibility.InNeu-
roethics in Practice. Edited by Anjan Chatterjee, Martha J.
Farah. New York: Oxford University Press; 2013:96-104.
Hyman SE: The neurobiology of addiction: implica-
tions for the voluntary control of behavior. In Neu-
roethics: An Introduction with Readings.EditedbyMartha
J. Farah. Cambridge, MA: MIT Press; 2010: 259-267.
Neuroethics education/training
Articles
Aldrich R: Nature, nurture and neuroscience:
some future directions for historians of education.
Paedagog Hist 2014, 50(6):852-860. doi:10.1080/
00309230.2014.948011.
Bell E: A room with a view of integrity and profes-
sionalism: personal reflections on teaching responsible
conduct of research in the neurosciences.Sci Eng Ethics
2015, 21(2):461-469. doi:10.1007/s11948-014-9545-9.
Buchman DZ, Borgelt E, Illes J: Core strategies for
the development of a clinical neuroethics education
program for medical residents in the clinical neuro-
sciences.JEMH 2009, 4(2):1-6.
Busso D, Pollack C: No brain left behind: conse-
quences of neuroscience discourse for education.
Learn Media Technol 2015, 40(2):168-186. doi:10.1080/
17439884.2014.908908.
Fukushi T, Sakura O: Neuroethics in Japancurrent
view and future visions.Brain Nerve 2009, 61(1):5-10.
Giordano J, Shook JR: Minding brain science in
medicine: on the need for neuroethical engagement
for guidance of neuroscience in clinical contexts.
Ethics Biol Eng Med 2015, 6(1-2):37-42. doi:10.1615/
EthicsBiologyEngMed.2015015333.
Griffith JL: Neuroscience and humanistic psychiatry: a
residency curriculum.Acad Psychiatry 2014, 38(2):177-
184. doi:10.1007/s40596-014-0063-5.
Han H: How can neuroscience contribute to moral
philosophy, psychology and education based on Aris-
totelian virtue ethics? Int J Ethics Edu 2016, 1(2):201-
217. doi:10.1007/s40889-016-0016-9.
Hardiman M, Rinne L, Gregory E, Yarmolinskaya J:
Neuroethics, neuroeducation, and classroom teaching:
where the brain sciences meet pedagogy.Neuroethics
2012, 5(2):135-143. doi:10.1007/s12152-011-9116-6.
Hook CJ, Farah MJ: Neuroscience for educators:
what are they seeking, and what are they finding?
Neuroethics 2013, 6(2):331-341. doi:10.1007/s12152-
012-9159-3.
Horvath JC, Donoghue GM: A bridge too far revis-
ited: reframing Bruers neuroeducation argument for
modern science of learning practitioners.Front Psy-
chol 2016, 7:377. doi:10.3389/fpsyg.2016.00377.
Hruby GG: Three requirements for justifying an
educational neuroscience.Br J Educ Psychol 2012,
82(Pt 1):1-23. doi:10.1111/j.2044-8279.2012.02068.x.
Illes J. Interview with Judy Illes.Trends Neurosci
2012, 35(9):521-523. doi:10.1016/j.tins.2012.06.006.
Becker et al. Philosophy, Ethics, and Humanities in Medicine (2017) 12:1 Page 18 of 32
Kalichman M, Sweet M, Plemmons D: Standards
of scientific conduct: disciplinary differences.Sci
Eng Ethics 2015, 21(5):1085-1093. doi:10.1007/
s11948-014-9594-0